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ABSTRACT 	  
Stem cells balance their self-renewal and differentiation potential by 
integrating environmental signals with the Transcriptional Regulatory 
Network (TRN). Moreover, the integration between extrinsic and intrinsic 
signals affects the maintenance of their epigenetic state, establishing an 
accurate cells identity. Although c-Myc transcription factors plays a major 
role in stem cells self-renewal and pluripotency, their mechanisms of 
actions and their ability to establish an epigenetic memory remains poorly 
defined. We addressed this point by profiling the epigenetic pattern and 
gene expression in Embryonic Stem (ES) cells, whose growth depends on 
conditional c-Myc activity. Here we show that c-Myc potentiates the Wnt/β-
Catenin signaling pathway, which cooperates with the transcriptional 
regulatory network in sustaining ES cells self-renewal. c-Myc activation 
results in the transcriptional repression of Wnt antagonists Dkk1 and Sfrp1 
through the direct recruitment of PRC2 on these targets. We found that, 
through these molecular mechanisms, c-Myc promotes pluripotency and 
self-renewal of ES cells by activating an alternative epigenetic program. 
Finally our data suggest that the consequent potentiation of the autocrine 
Wnt/β-Catenin signaling induces the transcriptional activation of the 
endogenous Myc family members, which in turn activates a Myc-driven 
self-reinforcing circuit. Thus, our data unravel a Myc-dependent self-
propagating epigenetic memory in the maintenance of ES cell identity. 
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SOMMARIO 	  
Le cellule staminali bilanciano la loro capacità di fare self-renewal e il loro 
potenziale di differenziamento integrando segnali ambientali con il Network 
di Regolazione Trascrizionale (TRN). Inoltre, l’integrazione tra segnali 
estrinseci e intrinseci influenza il mantenimento dello stato epigenetico, 
stabilendo una precisa identità cellulare. Sebbene il fattore di trascrizione 
c-Myc abbia un ruolo fondamentale nel mantenimento del self-renewal e 
della pluripotenza delle cellule staminali, i suoi meccanismi di azione e la 
sua capacità di stabilire una memoria epigenetica sono poco conosciuti. 
Abbiamo investigato su questo aspetto, analizzando il pattern epigenetico e 
l’espressione genica di cellule Staminali Embrionali (ES) cresciute in modo 
dipendente dall’attività di c-Myc. Mostriamo che c-Myc potenzia la via di 
segnalazione Wnt/β-Catenina, che coopera con il TRN, sostenendo il self-
renewal delle cellule staminali embrionali. L’attivazione di c-Myc causa la 
repressione trascrizionale degli antagonisti del Wnt, tramite il reclutamento 
diretto di PRC2 a livello di questi target. Il conseguente potenziamento 
della via Wnt/β-Catenina autocrina induce l’attivazione trascrizionale dei 
geni endogeni della famiglia Myc, i quali a loro volta attivano un circuito 
auto-regolatorio dipendente da Myc. I nostri dati descrivono un 
meccanismo di mantenimento della capacità di self-renewal delle cellule 
staminali embrionali basato su una memoria epigenetica indotta da Myc, in 
grado di auto-propagarsi. 
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1. INTRODUCTION 
1.1 Epigenetics 
The development of a complex organism requires a single genome to 
generate a multitude of cell phenotypes. The term “epigenetic” appeared in 
1942, along with the idea that genetics and developmental biology should 
be related each other. Conrad Waddington, by using the prefix epi- 
(“above” in Greek), suggested the existence of mechanisms besides the 
gene sequence that participate to the acquisition and maintenance of a 
specific cell identity [Holliday, 2006]. In addition to differentiation processes, 
a cell will be exposed to multiple events including mitotic and apoptotic 
signals, DNA repair, metabolite availability, drug exposure or the general 
chemical environment. All those events require more or less rapid 
activation or silencing of specific genes and these changes have to be 
maintained for a short or long term. Thus, the cell has to sense its 
environment in order to adapt the transcriptional levels of important genes 
and to maintain proper functions [Bird and Tweedie, 1995] (Figure 1.1). In 
the nucleus, the DNA is associated with histone proteins, RNAs and non-
histone proteins, in an organized structure named “chromatin fiber”. 
Chromatin components are subjected to chemical modifications, which are 
then interpreted by the transcriptional machinery for appropriate gene 
expression. Importantly, the activities of enzymes that add and remove 
those chemical “marks” have been shown to directly or indirectly depend on 
the environment. It has been proposed that the chromatin fiber, through 
modifying enzymes, acts as an environmental sensor and a signaling unit 
for the alteration of gene expression. Thus, it is of general interest to 
understand how environmental agents can impact on the activity of the 
genome in a short or long-term manner [Turner, 2009]. 
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Figure 1.1 Waddington model.  
Developmental restrictions can be illustrated as marbles rolling down from the hill into one of 
several valleys. In response to environmental stimuli, a particular signal transduction is 
activated, which leads to a defined epigenetic state, corresponding to different 
developmental potentials. [Modified from Mohammad and Baylin, 2010]. 
 
 
1.1.1 Chromatin organization and dynamics 
In eukaryotic cells, chromatin has a highly complex structure with several 
levels of organization (Figure 1.2). The nucleosome, basic unit of 
chromatin, consists of a histone octamer, which contains a pair of each of 
the core histone proteins: H2A, H2B, H3 and H4 [Luger et al., 1997], 
around which 147 base pairs of DNA are wrapped. A fifth histone protein, 
the lysine-rich histone H1, was found to sit on top of the nucleosome, 
outside the core octamer, and to associate with the DNA at the entry/exit 
sites of the nucleosome. Finally, the portion of free DNA between adjacent 
nucleosomes was called “linker DNA”. The length of linker DNA partly 
dictates nucleosome positioning and is considered as an important factor in 
chromatin function. In fact, it is likely that the position of nucleosomes in the 
chromatin fiber is a key determinant for the accessibility of various DNA-
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binding proteins and therefore affects gene regulation. However, how high 
levels of DNA compaction are established is not fully understood yet. 
A series of modifications to the DNA itself and to histone proteins have 
been characterized and termed “epigenetic modifications”. Many studies 
have correlated these “marks” with gene activity and several mechanisms 
describe how specific modifications induce transcriptional activation or 
silencing. Thus, it seems that the chromatin is not a simple packaging tool 
but also a platform for signaling that regulates gene expression. 
 
 
	  	  
Figure 1.2 The different levels of chromatin compaction.  
Chromosomal DNA is packaged inside nuclei with the help of histones, forming complexes 
called nucleosomes. Each nucleosome is composed of DNA wound 1.65 times around eight 
histone proteins. Nucleosomes fold up to form a 30-nanometer chromatin fiber, which forms 
loops averaging 300 nanometers in length. The fibers are compressed and folded into the 
chromatids of a chromosome.  
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1.1.2 Histone modifications 
All histone proteins possess unstructured N-terminal tails that extend out 
from the nucleosome core. These exposed tails are subjected to a wide 
variety of post-translational modifications such as acetylation, methylation, 
phosphorylation, ubiquitination or ADP-ribosylation (Figure 1.3). Specific 
histone modifications are deposited on specific residues. For instance 
lysine (K) can be acetylated, ubiquitinated or sumoylated, while serine (S) 
are phosphorylated. Methylation occurs on both lysine and arginine (R) and 
at different levels, as a residue can be mono-, di- or tri-methylated 
[Kouzarides, 2007]. Histone modifications alter transcription via direct or 
indirect effects. For instance, acetylation was shown to loose the chromatin 
fiber by neutralizing the positive charge of lysines. Thereby, the association 
of histones with DNA is weakened, allowing transcription factors and RNA 
polymerase to bind to regulatory sequences [Tse et al., 1998]. Histone 
modifications can also indirectly lead to changes in gene expression, as 
they are specifically recognized by proteins that will then impact on the 
function of the adjacent chromatin [Taverna et al., 2007]. 
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Figure 1.3 Histone modification patterns.  
Histone tails are subjected to many post-translational modifications that occur on specific 
residues. In the right combination, these modifications determine gene expression, therefore 
establishing the global and local, condensed or de-condensed chromatin states.  
 
 
1.1.3 DNA methylation 
DNA methylation is another epigenetic modification that has been 
consistently associated with transcriptional silencing. The covalent addition 
of a methyl (CH3) group occurs at the 5-carbon of the cytosine ring, 
resulting in 5-methylcytosine (5-mC). The addition of methyl groups is 
affected at different levels in cells and is carried out by a family of enzymes 
called DNA methyltransferases (DNMTs), which contain DNMT1, DNMT3a 
and DNMT3b. In mammals, DNA methylation occurs almost exclusively in 
the symmetric CG context. However, evidence of non-CG methylation was 
found in ES cells [Ramsahoye et al., 2000]. In mammals, the CG 
dinucleotides are mostly found near gene promoters in dense clusters, 
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called CpG islands. However, the distribution of DNA methylation in the 
genome is uneven, as a significant number of CG dinucleotides are 
unmethylated [Suzuki and Bird, 2008]. Slightly less than half of all genes 
are associated with CpG islands, and they are either housekeeping or 
tissue-restricted genes [Cross and Bird, 1995]. Although most of the CpG 
islands remain unmethylated, there are some important exceptions such as 
the methylation of the inactive X-chromosome or the CpG islands 
associated with imprinted genes [Ideraabdullah et al., 2008]. 
  
1.1.4 Histone modifications depositions 
Large families of specific enzymes are responsible for the deposition or 
removal of histone modifications. The enrichment of each mark is therefore 
the results of a dynamic process involving the activity of two enzymes that 
catalyze opposite reactions. 
The methylation state of histone tails also depends on the antagonistic 
actions of large families of enzymes. Lysine residues are methylated by 
lysine methyl-transferases (KMTs), that contain a conserved SET-domain 
responsible for the transfer of a methyl group from S-adenosyl-L-methionin 
(SAM), leading to the production of S-adenosyl-L-homocysteine (SAH). 
SET-domain containing enzymes have been classified into seven principal 
families (SUV39, SET1, SET2, EZ, RIZ, SMYD and SUV4) according to 
sequence homology and function. All KMTs are residue-specific, for 
instance the EZ family induce methylation of lysine 27 of histone H3.  
Lysine methylation has been considered as a dynamic modification since 
the discovery of lysine demethylases (KDMs), although not all residues 
have had a demethylases identified so far. 
As previously mentioned, histone proteins are subjected to a wide variety of 
post-translational modifications, in addition to methylation. Kinases and 
phosphatases respectively add and remove phosphate groups on serine, 
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threonine and tyrosine residues. Acetylases and deacetylases respectively 
add and remove acetyl groups on lysine residues. While ubiquitin-ligases 
and de-ubiquitin enzymes control lysine ubiquitination levels on H2A and 
H2B [Bannister and Kouzarides, 2011]. 
 
1.1.5 Binding histone modifications 
Many chromatin-associated proteins possess particular domains able to 
recognize and bind specific modifications. For instance, bromodomains are 
capable of interaction with acetyl residues, while a wide range of domains 
including chromodomains, Tudor domains or PHD fingers, recognizes 
methyl marks. Along with the diversity of histone modifications, the diversity 
of “reader” domains provides a new explanation for the multiple outcomes 
of chromatin marks [Taverna et al., 2007]. In fact, reader domains give a 
chance for modifying enzymes and chromatin-binding proteins to 
communicate. Thereby, a series of modifications can act together to 
regulate transcription in a specific manner [Jenuwein and Allis, 2001; 
Spotswood and Turner, 2002]. All chromatin-remodeling complexes, which 
move nucleosome to regulate DNA accessibility, recognize histone 
modifications and interact with chromatin modifiers [Clapier and Cairns, 
2009]. This complexity supports the idea of cross-talk between different 
histone marks and a code for transcription (Figure 1.4), called “histone 
code” [Jenuwein and Allis, 2001]. 
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Figure 1.4 Cross-talk between different histone modifications.  
Histone modifications are recognized by specific motifs of binding proteins. Therefore, when 
protein readers interact each other, they lead to cross-talk between histone marks. [Izzo and 
Schneider, 2010].  
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1.2 Embryonic Stem cells 
Embryonic Stem (ES) cells derive from the inner cell mass (ICM) of early 
blastocyst. Gene targeting experiments in ES cells have become a major 
tool to determine gene function in mammals [Capecchi, 2005]. Two main 
features characterize Embryonic Stem cells: the capacity for prolonged 
self-renewal and the potential to give rise to any cell type comprising the 
adult organism. In fact, ES cells injected into blastocyst are able to 
generate a chimeric animal, confirming their pluripotent nature. Since then, 
many studies have monitored ES cells differentiation pathway and 
identifying specific marker. Based on those studies, protocols that involve 
the spatial rearrangement of cells in culture and exposure to specific 
environmental factors were described, in order to drive differentiation of ES 
cells into defined lineages (Figure 1.5) [Murry and Keller, 2008]. Hence, 
differentiation of ES cells in culture constitutes a precious tool to study the 
establishment and long-term maintenance of specific gene expression 
programs that define cell identity. A full understanding of pluripotency and 
cell fate is crucial for the development of regenerative medicine and to 
speculate on the mechanisms of tumorigenesis, as cancer cells can 
present a stem cell-like phenotype.  
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Figure 1.5 ES cells differentiation in culture.  
It is possible to maintain ES cells in a pluripotent state with the addition of LIF into the 
medium. On the bases of specific environmental stimuli, they also can differentiate in vitro in 
the cells of the three embryonic layers [Modified from Murry and Keller, 2008].  
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1.2.1 Genetic regulation of pluripotency 
In vivo, pluripotency is a transitional state, since in development most of the 
cells that compose an embryo are engaged in a differentiation pathway at a 
very early stage. However, during this short period of time, cells have to 
maintain the pluripotent state together with a high rate of proliferation. 
Many studies have shown that gene expression in ES cells is very variable, 
leading to heterogeneous populations poised for a range of lineage 
specification [Silva and Smith, 2008]. However, in 2006 Yamanaka and co. 
work showed that only four transcription factors were indispensable to 
generate induced Pluripotent Stem (iPS) cells: Oct4, Sox2, Klf4 and c-Myc 
[Takahashi and Yamanaka, 2006]. Finally, also Nanog was identified as 
another major player in pluripotency maintenance [Mitsui et al., 2003]. 
The cross-talk between these essential transcription factors and chromatin 
regulators is required to maintain ES cells identity, through activation of ES 
cells-specific genes and repression of lineage-specific developmental 
genes [Orkin and Hochedlinger, 2011]. Since then, many studies have 
established three distinct ES cells regulatory module: Transcriptional 
regulatory network (TRN), c-Myc and Polycomb Repressive Complexes 
(PRCs), that are able to interact with one another and sustain ES cells 
pluripotency [Chen et al., 2008; Kim et al., 2010]. The TRN is composed of 
ES cells factors Oct4, Sox2 and Nanog, which activate the transcription of 
ES cells-specific genes and repress the developmental genes [Kim et al., 
2010; Young, 2011]. c-Myc, which is part of the four TFs involved in iPS 
cells generation, seems to work separately from the TRN [Sridharan et al., 
2009; Soufi et al., 2012]. Finally, the Polycomb Repressive Complexes, 
composed by PRC1 and PRC2, repress lineage-specific genes [Margueron 
and Reinberg, 2011]. 
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1.2.2 Chromatin structure in ES cells 
Since it is now well accepted that chromatin structures are associated with 
the transcriptional activity of genes, the purpose of many recent studies has 
been to describe a putative epigenetic signature of ES cells. The challenge 
for those cells is to maintain pluripotency while preparing for differentiation, 
to repress developmental genes but keep them poised for transcription. 
Hence, the genome in ES cells must be in a highly plastic state so as to 
have the capacity to enter any one distinct differentiation pathway 
[Meshorer et al., 2006]. However, until now the molecular mechanisms for 
self-renewal, maintenance of pluripotency and lineage specification are 
poorly understood. 
ES cells seem to be characterized by a distinct higher order global 
chromatin structure. Their nuclei are larger than those of differentiated cells 
and are more riche in less compact euchromatin and particular epigenetic 
features. Once the differentiation program starts, a gradual and organized 
redistribution of the genome occurs inside the nucleus, resulting in a rapid 
reorganization of the genome that accumulates highly condensed, 
transcriptionally inactive heterochromatin [Arney and Fisher, 2004].  
In order to guarantee such a dynamic chromatin structure, ES cells are 
characterized by the existence of an unusual chromatin signature 
represented by the so called “bivalent domains” [Bernstein et al., 2006]. 
They are large regions of chromatin in which the repressive mark 
H3K27me3 co-localizes with peaks of the activating mark H3K4me3. 
Bivalent domains were often associated with low expression and were 
rapidly switched on according to differentiation program, reinforcing again 
the concept of “poised chromatin”. In addition to H3K27me3 marks, the 
Polycomb complex deposits also monoubiquitination on lysine 119 of H2A 
(H2AK119ub), in order to retain the poised polymerase on bivalent domain 
[Stock et al., 2007]. In addition to histones, many other DNA-binding 
proteins, such as Transcription Factors (TFs) could affect the chromatin 
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structure, in order to rapidly switch the gene expression on or off, by 
creating transient interactions with chromatin, with residence times that can 
range from few minutes to few seconds [Meshorer et al., 2006]. 
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1.3 Myc genes 
One of the most studied groups of genes is the Myc oncogene family, 
comprising c-Myc, N-Myc and L-Myc. c-Myc gene was discovered in the 
beginning of the 1980s and its protein was originally discovered as the 
homolog to the viral oncogene of the avian myelocytomatosis retrovirus (v-
myc) [Vennstrom et al., 1982]. Regulation of c-Myc expression is crucial in 
order to obtain normal cell functions and, since it regulates the transcription 
of a wide range of genes, even small changes in its expression can 
influence cell growth, proliferation, apoptosis, differentiation and 
transformation [Meyer and Penn 2008; Levens, 2010]. Furthermore, 
targeted gene disruption of both Myc alleles in ES cells leads to embryonic 
lethality at day 9.5-10.5, which highlights the crucial role of Myc in normal 
growth control during mammalian development [Davis et al., 1993]. 
 
1.3.1	  Conserved	  regions	  and	  the	  interaction	  with	  cofactors	  
The C-terminal part of c-Myc contains a basic helix-loop-helix-leucine 
zipper (bHLH-LZ) motif (Figure 1.6). Myc protein can bind to DNA through 
its bHLH domain, while the LZ domain allows the dimerization with its 
partner Max (Figure 1), another bHLH transcription factor [Eilers and 
Eisenman, 2008]. Myc/Max heterodimers are capable of binding specific 
DNA sequences such as the E-box sequence (5’-CACGTG-3’) and 
subsequently activate transcription of target genes [Adhikary and Eilers 
2005]. Furthermore, Max association and DNA binding are required for 
transcriptional activation of many genes involved in cell proliferation, 
metabolism, stemness and apoptosis [Blackwell et al., 1990; Amati et al., 
1993]. In addition to the bHLH-LZ domain, c-Myc is composed of a basic 
region involved in determining sequence-specific DNA binding [Ryan and 
Birnie, 1996].  
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Figure 1.6 Schematic illustration of c-Myc showing the conserved regions and the 
interaction with co-factors.  
The N-terminal Transactivation Domain (TAD) includes MBI and MBII domains. The C-
terminal region contains the bHLH-LZ motif. [Adapted from Adhikary et al., 2005]. 
 
 
Finally, c-Myc presents a Trans Activation Domain (TAD), located at the N-
terminal region, which is composed of two Myc homology Boxes, named 
Myc Box I-II (MBI-II). The so called “MB domains” are highly conserved 
between c-Myc, N-Myc and L-Myc and across species [Cowling and Cole, 
2006] and are essential for c-Myc transforming activity, transcriptional 
activation and repression, since they are necessary for the interaction with 
a wide range of co-factors. Among those, chromatin remodelling 
complexes, such as Histone Acetylation complexes (HAT) or Polycomb 
Repressive Complexes, play an important role.  
 
1.3.2 c-Myc-mediated transcriptional activation and repression 
1.3.2.1 Transcriptional activation 
c-Myc can facilitate chromatin opening by recruitment of HAT complexes to 
chromatin. TRRAP and GCN5 are part of the HAT complex STAGA and the 
TAD domain of c-Myc is shown to bind TRRAP, which in turn binds GCN5 
and acetylates histone [McMahon et al., 2000]. Moreover, other chromatin 
remodelling protein complexes, such as TIP60, interact with c-Myc and 
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TRRAP, which in turn recruit the TIP60 complex subunits TIP48, TIP49 and 
p400 to the chromatin [Frank et al., 2003]. 
RNA polymerase III (Pol III) transcription is necessary for cell growth and it 
has been shown that c-Myc binds to the Pol III-specific Transcription Factor 
TFIIIB, therefore activating Pol III transcription. Pol III plays a pivotal role in 
the cell cycle, since it is involved in the transcription of ribosomal protein 
genes and in the synthesis of transfer RNA (tRNA) and 5S ribosomal RNA 
(5S rRNA), in order to favour protein expression in a growing cell.  
Cells overexpressing c-Myc show altered expression of Pol II target genes. 
The c-Myc TAD domain is shown to induce Pol II phosphorylation through 
the interaction with C-Terminal Domain (CTD) kinases that phosphorylate 
Pol II CTD domain [Eberhard and Farnham 2001]. Moreover, recent works 
shown that transcriptional activation can be affected by Myc/Max complex-
mediated recruitment of Pim1 to the chromatin of target genes, where it 
phosphorylates histone H3 at Ser 10 [Zippo et al., 2007]. 
 
1.3.2.2 Transcriptional repression 
In addition to transcriptional activation, c-Myc is able to repress specific 
target genes. So far, the repressive mechanisms were not well elucidated, 
even if c-Myc seems to be responsible of the repression of at least 15% of 
target genes [Meyer and Penn 2008]. One of the mechanisms described 
until now argues that c-Myc interacts with Miz-1, therefore interfering with 
the formation of a Miz1-p300 complex and inhibiting Miz1-mediated 
transcriptional activation [Staller et al., 2001]. However, so far no studies 
have elucidated the direct interaction between c-Myc and chromatin 
modifiers in order to inhibit the expression of target genes. Our results 
describe the binding between c-Myc and PRC2 complex, leading to 
repression of c-Myc/PRC2 co-bound genes. 
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1.3.3 Regulation of c-Myc stability 
The cellular half-life of the c-Myc protein is very short, approximately 20-30 
minutes [Hann and Eisenman, 1984] before it is targeted for proteosome 
degradation. The role of post-translational modifications in c-Myc stability 
and activity has been studied extensively during the years, and several 
different modifications, such as phosphorylation, ubiquitination, 
glycosylation and acetylation have been described. Up to today, studies on 
phosphorylated c-Myc clearly show a role in the regulation of c-Myc 
biological activities, whereas the biological effects of the other modifications 
are still more ambiguous [Hann, 2006]. 
 
1.3.3.1 Phosphorylation at Ser62 and Thr58 
The phosphorylation at Ser62 and Thr58 in MBI is sequential (Figure 3) 
and initial phosphorylation of Ser62 is required for Thr58 phosphorylation 
[Lutterbach and Hann, 1994]. Gsk3β is shown to phosphorylate Thr58 
[Gregory et al., 2003]. The activity of Gsk3β is regulated by the PI3K 
pathway: phosphorylation of Gsk3β by PI3K-induced Akt kinase inhibits 
Gsk3β. In-vivo phosphorylation of Ser62 stabilizes c-Myc [Sears et al., 
2000] and phosphorylation of Ser62 is mediated by MEK-activated ERK 
and Cdk2 [Hydbring et al., 2010]. 
The tumour suppressor Axin1 has been proposed to facilitate the formation 
of a degradation complex for c-Myc, by favouring the interaction between c-
Myc and Gsk3β, PPA2 and Pin1 [Arnold et al., 2009]. 
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1.4 The Polycomb Group Family 
The Polycomb Group (PcG) represents a family of transcriptional 
repressors that play an important role in maintaining the repressed state of 
genes in the developmental regulatory transcriptional programs. PcG 
genes were discovered in the fruitfly Drosophila melanogaster more than 
30 years ago as regulators of anterior-posterior body patterning through 
repression of the homeotic genes [Lewis, 1978]. Consequent identification 
of the trithorax group (trxG), that activate homeotic genes, led to a concept 
of a balance between silencing and activating factors that together provide 
cellular memory at different stages of development [Shao et al., 1999]. 
Subsequent work has shown that PcG and trxG groups form large 
multiprotein complexes that directly interact with the chromatin at their 
target genes [Schuettengruber et al., 2007]. In Drosophila, specific DNA 
regulatory elements, named “Polycomb” and “Trithorax response elements” 
(PRE and TRE respectively), were found to be necessary and sufficient for 
recruitment of both PcG and trxG complexes [Schwartz and Pirrotta, 2007]. 
Recently, PcG and trxG genes have also been identified in vertebrates, 
where they are involved in many biological functions: cell proliferation 
[Martinez and Cavalli, 2006], stem cell identity maintenance, cancer 
[Sparmann and van Lohuizen, 2006], genomic imprinting and X inactivation 
[Delaval and Feil, 2004; Heard, 2005]. 
 
 
1.4.1 Polycomb Complexes 
The composition of these complexes is context-dependent. However, in 
vertebrates the PcG-mediated repression is performed through the 
combined activity of two Polycomb Repressive Complexes (PRCs): the 
initiator complex PRC2, and the maintenance complex PRC1. Although 
biochemical analysis showed that PRC1 and PRC2 are independent 
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entities with separate function and timing [Shao et al., 1999; Ng et al., 
2000], a transient interaction between components of both complexes has 
been observed. Furthermore, it has been reported that complex formation 
is important for PcG proteins stability [Schwartz and Pirrotta, 2008]. 
 
1.4.1.1 The PRC1 complex 
The core of the PRC1 complex includes one subunit of the PCGF (BMI1, 
MEL18 or NSPC1), CBX, HPH, and RING1 paralog groups (Figure 1.7) 
[Levine et al., 2002; Whitcomb et al., 2007]. The RING1 protein has 
monoubiquitylation E3 ligase activity specific for the lysine 119 of H2A 
(H2AK119ub), a mark associated to repressive chromatin structure [Wang 
et al., 2004]. In addition to the four core subunits of PRC1, a number of 
other proteins have been reported to associate with the complex. 
 
Figure 1.7 PRC1 complex.  
The diagram shows on the left the classical PRC1 complexes, while on the right the so-
called PRC1-like complexes. RING1A/B is the subunit endowed with catalytic activity. The 
“pocket” shape of the CBX proteins represents the chromodomain that recognize 
H3K27me3. X, Y and Z denote various proteins, such as SCMH1/2, FBXL10, E2F6 and 
JARID1D, that could contribute to the formation of PRC1-like complexes. [Modified from 
Margueron and Reinberg, 2011]. 
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1.4.1.2 The PRC2 complex 
The core of PRC2 comprises two homologous of the Enhancer of Zeste 
(EZH1/2), the homologue of Embryonic Ectoderm Development (EED) and 
the homologue of Suppressor of Zeste (SUZ12) (Figure 1.8). The EZH1 
and EZH2 proteins catalyze the trimethylation at lysine 27 of histone H3 
(H3K27me3), another typical epigenetic silencing mark [Cao et al., 2002]. 
Genetic experiments in mice have shown how the integral PRC2 complex 
plays a key role during development, since the absence of the PRC2 genes 
was found to induce early embryonic lethality [Pasini et al., 2004]. 
Additional components associated with the PRC2 complex are the 
Retinoblastoma Binding Protein 4 (RBBP4) and 7 (RBBP7). Together with 
SUZ12, these two proteins were shown to be required for the association of 
EZH2 with nucleosomes [Cao et al., 2002; Nekrasov et al., 2005]. A recent 
work showed that PRC2 requires a particular protein co-factor, called 
AEBP2, to tri-methylate Lysine 27 of histone H3 [Ciferri et al., 2012]. 
Finally, additional variation in the complex formation is induced by the 
different expression level of EZH2 or EED isoforms, which play a pivotal 
role in directing the enzimatyc activity of the complex [Kuzmichev et al., 
2002; Kuzmichev et al., 2005]. 
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Figure 1.8 PRC2 cmplex.  
The diagram shows the three core subunits of PRC2. The catalytic subunit EZH2, that 
contains a SET domain for histone H3K27 methylation, and two non-catalytic subunits 
SUZ12 and EED. In addition, different co-factors may be associated with the core of PRC2 
in order to increase the histone methyltransferase activity. [Modified from Margueron and 
Reinberg, 2011]. 
 
 
1.4.2 Mechanism of PcG-mediated Repression 
The current model of gene silencing by PcG complexes is summarized in 
Figure 1.9. Following recruitment of the PRC2 complex to chromatin, the 
histone methyltransferases activity of EZH2 converts the lysine 27 of 
histone H3 to a trimethylated form (H3K27me3) [Cao et al., 2002; Czermin 
et al., 2002]. This mark is then recognized by the chromodomain of the 
PRC1 complex, which catalyzes the ubiquitination of histone H2A on lysine 
119 (H2AK119ub). In mice, it has been shown that the Ring1B E3 ligase 
protein is the catalytic subunit, while both Ring1A and Bmi1 have been 
identified as important enhancers of enzymatic activity [Cao et al., 2005; 
Buchwald et al., 2006]. However, this model has been challenged by the 
fact that it does not explain how PRC2 is recruited to chromatin and how 
the binding of PRC1 results in stable repression. For this reason, a 
complete understanding of their functions in gene silencing remains to be 
deciphered. 
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Figure 1.9 Classical model of PcG-mediated repression.  
Following recruitment of the PRC2 complex to chromatin, EZH2/1 catalyzes the 
trymethylation of H3K27 (H3K27me3). In the next step, the PRC1 complex recognizes and 
binds the H3K27me3 mark. The ubiquitin E3 ligase activity of the complex mediates the 
ubiquitination of H2AK119 (H2AK119ub). These events result in the stable repression of 
transcription. [Modified from Sauvageau and Sauvageau, 2010]. 
 
 
1.4.3 PcG in Stem Cells and Cancer 
Recent genome-wide screens of PcG protein binding sites in mouse ES 
cells identified more than a thousand potential target genes [Boyer et al., 
2006; Bracken et al., 2006]. The most important concept that emerge from 
this analysis is that PcG proteins are important for maintaining pluripotency 
of ES cells and the identity and self-renewal capacity of somatic stem cells 
[Ringrose and Paro, 2007], while their disrupted levels have been 
increasingly linked to aberrant proliferation in cancer [Sparmann and van 
Lohuizen, 2006]. 
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1.4.3.1 PcG proteins in stem cell self-renewal 
Even though the lack of core PRC2 components leads to the global loss of 
H3K27 methylation, H3K27me3 and PcG-mediated gene silencing were 
maintained at a select number of key developmental genes, thanks to the 
activity of Ezh1 [Shen et al., 2008]. Indeed, the interaction between Ezh1 
and Eed can maintain ES cell self-renewal, but not pluripotency, which 
additionally requires Ezh2 and Suz12 [Pasini et al., 2004; Ezhkova et al., 
2009].  
Thus, PcG-mediated repression has an important role in the maintenance 
of ES cells self-renewal and pluripotency and in the priming of 
differentiation, whereas they are required in the maintenance of somatic 
stem cells identity and self-renewal. The significance of PcG proteins in 
pluripotency is further supported by the fact that Sox2, Oct4 and Nanog co-
localize with PcG proteins on the promoters of target genes [Boyer et al., 
2006; Lee et al., 2006] 
 
1.4.3.2 PcG in cancer 
Aberrant expression of PcG proteins were found to be implicated in 
tumorigenesis. Human BMI1 has been found to be highly expressed in 
leukaemia and lymphoma, colorectal cancer, liver cancer, breast cancer, 
medulloblastoma and glioma [Bruggeman et al., 2007]. CBX7 have been 
found to be involved in lymphomas and prostate cancer [Gil et al., 2005], 
whereas EZH2 is commonly found to be overexpressed in various types of 
cancer, including leukaemia, prostate cancer and breast cancer and it is 
considered a marker of aggressive cancer [Bracken et al., 2006; Kleer et 
al., 2003]. SUZ12 is also found to be deregulated in various cancers, 
including colon, breast and liver cancer [Kirmizis et al., 2003]. 
During last years emerging evidences indicated that tumors contain a 
subset of cancer cells that display properties of stem cells, such as the 
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ability to self-renew and to spawn differentiated progeny. In this context, the 
dual role of PcG proteins in cancer and stem cells is unlikely to be 
coincidental. Rather it could fit with the cancer stem cell hypothesis, which 
holds that the origin of tumours is based on stem cell properties. The 
emerging understanding of what governs cellular identity plasticity has 
shed light on processes involved in reversing differentiation and acquiring 
self-renewal capacity. The role of PcG proteins in resetting the repression 
of differentiation-specific genes is likely to be an important topic [Jaenisch 
and Young, 2008]. 
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2. AIMS OF THE STUDY 
Mouse ES cells are derived and maintained by using various empirical 
combinations of feeder cells, cytokine leukaemia inhibitory factor (LIF) and 
fetal calf serum, which lead mainly to the activation of Stat3 signalling. 
[Niwa et al., 1998]. However the ES cells dependency on LIF/Stat3 
signalling could be circumvented by either the inhibition of pro-
differentiation regulators [Kaji et al., 2006; Ying et al., 2008] or by the 
enforced expression of pluripotency factors [Chambers et al., 2003; Niwa et 
al., 2009]. Among these, the Myc family members c-Myc and N-Myc have 
been described to modulate self-renewal and pluripotency of ES cells 
[Cartwright et al., 2005]. However the molecular mechanisms underlying 
their action are poorly understood. In this work we aimed to distinguish and 
characterize the molecular mechanisms through which c-Myc transcription 
factor maintains self-renewal and pluripotency of ES cells. 
Recent works showed that transcription factors networks, activated by 
environmental stimuli, represent the basic building block for the formation 
of cellular memory. However, the molecular mechanisms were poorly 
investigated so far.  Here we undertook to elucidate the role of c-Myc in the 
establishment of an epigenetic memory in ES cells. 
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3. MATERIALS AND METHODS 
3.1 Cell Culture 
All the cell lines used are listed in Table 2.1 and were kept under 
conventional cell culture conditions at 37°C and 5% CO2. 
 
Cells Description Source 
mES cells line 
R1 
Mouse Embryonic Stem cells Cartwright et al., 
2005 
mES cells line 
R1 MycT58AER 
Mouse Embryonic Stem cells 
expressing c-Myc fused with 
Estrogen Receptor 
Cartwright et al., 
2005 
HEK-293T Human embryonic kidney 
fibroblast immortalized by hTERT 
ATCC 
EpiSC Epiblast stem cells carrying an 
Oct4GiP transgene 
Guo et al., 2009 
NIH-3T3 Mouse embryonic fibroblast ATCC 
IMEC Human immortalized mammary 
epithelial cells 
DiRenzo et al., 
2002 
Table 3.1 cell lines 
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3.1.1 Cell culture and treatment 
mouse Embryonic Stem cells: are an adherent male ES cells line grown 
on 0.1% gelatine-coated plate (Sigma, cat. N°G1393) in Dulbecco’s 
modified eagles medium (DMEM) (Euroclone, cat. N°ECB7501L). The 
culture medium was supplemented with 15% fetal bovine serume (FBS) 
(Millipore, cat. N°ES-009-B), 1% penicillin/streptomycin (Pen/Srep) 
(Euroclone), 1% Glutamax (Gibco, cat. N°35050), 1x non-essential amino 
acids (NEAA) (Euroclone, cat. N°ECB3054D), 100 µM 2-mercaptoethanol 
(Gibco, cat. N°31350) and 10U/µl Leukaemia inhibitory factor (LIF/ESGRO) 
(Millipore, cat. N°ESG1107). Cells were split every two days, usually 5x103 
cells/cm2. Briefly, after three washes in PBS the cells were detached from 
the plate using trypsin-EDTA 1x (Euroclone, cat. N°ECB3052D). Medium 
was then added to neutralise the trypsin and pipetted in order to divide at 
single cell, centrifuged for 5 minutes at 300g and resuspended in warm 
fresh medium. The medium was changed every day. 
 
HEK-293T and NIH-3T3: were grown in DMEM medium supplemented wit 
10% FBS (Euroclone, cat. N°ECS0180L), 1% Pen/Strep, 1% L-glutamine 
(Euroclone), 1x NNEA. Cells were split with ratio 1:10 every three days as 
previous described.  
 
Epiblast stem cells: EpiSCs were grown on plate coated with 15 µg/ml of 
fibronectin (Sigma, cat. N°F1141) in DMEM-F12/Neurobasal medium 1:1 
(Gibco, cat. N°21103) supplemented with 1x N2 supplement (Gibco, cat. 
N°17502), 1x B27 supplement (Gibco, cat. N°17504), 0,033% BSA 
(Millipore), 1% Pen/Strep, 1x L-glutamine, 12 ng/ml bFGF (Peprotech, cat. 
N°100-18B) and 20 ng/ml ActivinA (R&D, cat. N°338-AC). Cells were split 
every three days, usually in a 1 to 10 ratio but this varied according to cell 
density. Cells were detached from the plate using Collagenase IV 5 mg/ml 
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(Gibco, cat. N°17104). Medium was then added and cells were slightly 
pipetted in order to obtain small clumps, centrifuged for 5 minutes at 300g 
and resuspended in warm fresh medium. On alternate days, cells were 
supplemented with warm fresh medium. 
 
IMEC: are a human cell line derived from epithelial cells of the mammary 
gland, immortalized through the overexpression of hTERT [DiRenzo et al., 
2002]. IMEC cells were grown in MEBM (Mammary Epithelial Basal 
Medium) (Lonza, cat. N°LOCC4136) supplemented with 13 mg/ml of 
bovine pituitary extract (BPE), 20 ng/ml of Epidermal Growth Factor (EGF), 
10 µg/ml of Insulin, 0.5 µg/ml of Hydrocortisone and 1% Pen/Strep. For 
mammosphere culture, 4x103 IMEC cells were seeded onto plate Ultra Low 
Attachment (Corning Costar) in MEBM medium supplemented with 20 
ng/ml of EGF, 10 µg/ml of insulin, 0.5 µg/ml of hydrocortisone, 1% 
Pen/Strep, 1x B27 supplement, 20 ng/ml of bFGF and 5 µg/ml of heparin 
(Sigma, cat. N°H3149). 
 
Reagents: 
All cells were treated with the following reagents in the described 
experimental procedures: 4-OHT 50 nM (Sigma, cat. N°H6278); Dkk1 100 
ng/ml (R&D, cat. N°5897-DK); Sfrp1 100 ng/ml (R&D, cat. N°1384-SF); 
Wnt-3a 100 ng/ml (R&D,  cat. N°5036-WN); CHIR99021 3µM (abcam, cat. 
N°Ab120890); PD 0325901 1 µM (Sigma, cat. N°PZ0162); EPZ005687 
1µM (BioVision, cat. N°2364); GSK126 2µM (BioVision, cat. N°2282); 
AG490 5µM (Invivogen, cat. N°tlrl-ag4); Jak1 1µM (Millipore, cat. 
N°420099); XAV939 3µM (abcam, cat. N°ab120897). 
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3.1.2 Freezing and recovery of cells 
All cells were grown to ~80% confluency and detached as described 
above. After centrifugation the pellet cells were resuspended into 1 ml of 
pre-cooled freezing solution (50% FBS, 40% medium and 10% DMSO). 
The cells were afterwards transferred into a cryotube (Nunc) and frozen 
gradually in a freezing container (Nalgene) at -80°C. After about 24h, the 
tubes were transferred in the liquid nitrogen cell storage (-180°C). 
For recovery of the cells after freezing, the frozen cells were swiftly 
transferred from liquid nitrogen to a 37°C waterbath and incubated until just 
thawed and then transferred to a culture dish containing pre-warm medium. 
 
3.1.4 Alkaline phosphatase assay 
Alkaline phosphatase activity is a specific marker of undifferentiated cells. 
The enzyme activity was detected by histochemical staining of fixed 
adherent cells. Briefly, medium was removed from the plate and cells were 
fixed for 5 min with 4% PFA. Cells were then rinsed three times in 100 mM 
TrisHCl ph 8 and incubated for 30 min in staining solution using VECTOR 
Red Alkaline Phosphatase (AP) Substrate Kit (Vector Lab, cat. N°SK-5100) 
according to manufacturer’s guidelines and scanned with Nikon Eclipse Ti 
instrument to score positive colonies. 
 
3.1.5 Differentiation of ES cells 
3.1.5.1 EBs differentiation 
Cells were trypsinised and replated 100 cells/well in non-adherent 96-well 
plates in DMEM supplemented with 10% KSR (Invitrogen, ), 1x NNEA, 
2mM L-glutamine and 1mM sodium pyruvate (Euroclone) without LIF. After 
4 days of differentiation EBs were transferred onto petri dishes in order to 
continue differentiation without the EBs could attach the plate. 
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3.1.5.2 EpiLC transition 
ES cells were induced to differentiate by following a method previous 
published [Hayashi et al., 2011]. Briefly, cells were trypsinised and replated 
2x104 cells/cm2 onto plate coating with 16.7 µg/ml in N2B27 medium 
containing Activin A (20 ng/ml), bFGF (12 ng/ml) and KSR (1%). The 
medium was changed every day 
 
3.1.6 Transfection with DNA (plasmids) 
The cells were counted and seeded in plate 24h prior to transfection. The 
number of cells seeded varied among the cell lines and was calculated 
such that the cells would be ~80% confluent on the day of the transfection. 
The transfection mix was prepared using Lipofectamine 2000 (Invitrogen, 
cat. N°11668) with a ratio of 3 µl of Lipofectamine 2000 for every 1 µg of 
total DNA transfected. 
 
3.1.7 Production of lentivirus and retrovirus 
Lentivirus and retrovirus were produced by transient calcium phosphate 
transfection of HEK-293T cells with viral plasmids (shRNA, pBABE-
MycT58AER or PGK-H2BeGFP) and the corresponding packaging plasmids 
(pREV, VSV-G and pMDLg/pRRE). Additional information regarding the 
plasmids has been included in Table 2.2. The day before transfection, 
7.5x106 HEK-293T cells were seeded in 150 mm culture dish in complete 
DMEM. 2 h before transfection the medium from the plate was removed 
and replenished with ISCOVE’s DMEM (Euroclone, cat. N°) medium 
supplemented with 10% of FBS, 1% Pen/Strep, 2mM of L-glutamine, 1 mM 
sodium pyruvate and 1x NEAA. The transfection mix was prepared by 
adding 32 µg of transfer plasmid, 6.25 µg of pREV and 9 µg of the VSV-G 
plasmid and 12.5 µg of pMDLg/pRRE. The final volume of the plasmid mix 
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was adjusted to 1.125 ml with ddH2O. 0.125 ml of 2.5 M CaCl2 solution was 
added to the plasmid mix and the mixture was vortexed gently. The final 
transfection mixture was prepared by drop wise addition of the CaCl2-DNA 
mix to 1.250 ml of HEPES-buffered saline (HBSS) while vortexing the 
solution. The mixture was incubated at room temperature for 15 min to 
allow formation of DNA precipitates. Three millilitre aliquots were 
distributed into each 150 mm culture dish and the dishes were gently 
swirled. Cells were incubated for 18 h at 37°C. The next day the medium 
was changed with complete DMEM. Virus-containing supernatant was 
harvested at 48 h after transfection and concentrated using 
ultracentrifugation. 
Supernatant containing virus particle were distributed into SW32 Ti open-
top conical tubes (Beckman). The tubes were centrifuged at 50.000g for 2 h 
at 4°C in a Beckman ultracentrifuge using a SW32 Ti ultracentrifuge rotor 
(Beckman). When centrifugation was completed the supernatants was 
removed and the tubes were inverted and left to dry for 5 minutes. The 
pellet from each centrifuge tube was resuspended in 80 µl of PBS by gently 
pipetting up and down and kept for 30 min at 4°C in gently agitation. Virus-
containing solution was aliquot in sterile microcentrifuge tubes and stored 
at -80°C.  
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Plasmid Description Source of 
reference 
pBABE-MycT58AER Retroviral expression vector 
encoding MycT58A fused with 
hormone binding domain 4-OHT 
Addgene 
pLKO.1 shc-Myc TRCN0000042515 Open Biosystem 
pLKO.1 shN-Myc TRCN0000020694 Open Biosystem 
pLKO.1 shβ-
Catenin 
TRCN0000012690 Open Biosystem 
pLKO.1 shEed TRCN0000095722 Open Biosystem 
pLKO.1 shEzh2 TRCN0000039042 Open Biosystem 
PGK-H2beGFP Lentiviral expression vector 
encoding H2B histone fused 
with GFP 
Addgene 
pREV Expresses the protein to 
activate nuclear export of viral 
mRNAs 
Addgene 
VSV-G Expresses the glycoprotein of 
the vescicular stomatitis virus 
Addgene 
pMDLg/pRRE Contains Gag and Pol proteins Addgene 
Table 3.2 Viral plasmids 
 
3.1.8 Retrovirus or Lentivirus Transduction 
ES cells were counted and seeded in 6 well culture dishes in complete 
DMEM medium (section 2.1.1) 8h before infection. Subsequently, the 
medium from wells containing the cells to be infected was changed with 
fresh growth medium containing polybrene (Sigma, cat. N°107689), a 
cationic polymer used to increase the efficiency of transduction. 
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Concentrated virus suspension was added to individual wells containing 
target cells at an MOI of 1 and the cells were incubated at 37°C for 24 h. 
The following day the medium was removed and replenished with fresh 
growth medium containing appropriate antibiotic for selection (Puromycin, 1 
µg/ml). 
 
3.1.9 Cell cycle analysis with a FACS machine 
For analysing the cell cycle distribution, cells were harvested by 
trypsinization for approximately 10 min to minimize clump formation, and all 
the cells (including the floating cells) were collected and pelleted by 
centrifugation at 300g for 5 min. The cell pellet was resuspended in 300 µl 
of PBS and fixed by the addition of 700 µl cold ethanol, overnight at 4°C. 
The next day the fixed cells were pelleted by centrifugation at 300g and the 
cell pellet was washed once with cold PBS. The cell pellets were then 
resuspended for 40 min in 200 µl of staining solution composed of 10 µl 
RNAse A and 2 µl of propidium iodide (100mg/ml) per 100 µl of PBS. 
Propidium iodide (PI) is an intercalating dye that fluoresces more strongly 
when bound to DNA. Therefore the amount of DNA present in the cell 
would be proportional to the PI signal. RNAse A was used to degrade RNA 
for the DNA only to be quantified. The cells were then sorted according to 
their size and DNA content using a FACScan flow cytometer (BD 
FACSCanto). The FACS data were further analysed using the software 
FlowJo (FlowJo inc.) to measure the percentage of cells in each cell cycle 
phase. 
 
3.1.10 Time-lapse video microscopy 
For live imaging analysis ES cells were seeded in 24 well plate (Ibidi, 
cat. N°82406) coated with 15 µg/ml Fibronectin. Time-lapse video 
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microscopy and single cell tracking of ES cells expressing H2B-eGFP 
were carried out continuously for 48h at 37° C and 5% CO2 using the 
Eclipse Ti fully automated system (Nikon). Images of fluorescent cells 
were acquired every 20 minutes with 20x Plan Apo l objective (Nikon) 
using a LED illumination system combined with a CMOS camera 
(Andor) for the detection. Single cell tracking was performed using the 
TTT software as described previously [Rieger and Schroeder, 2009] 
and movies were assembled using Image J software. 
 
3.1.11 Teratoma Assay 
Teratoma formation was assessed by injecting intracranial ES cells (LIF, 
Myc, -Myc) in immuno-compromised mice (CD1 nude). Briefly, 2x105 cells 
suspended in 2 ml of DMEM were delivered into the right striatum by 
stereotactic injection. The following coordinates were used: antero-
posterior = 0; mediolateral = 2.5 mm; dorso-ventral = 3 mm. Mice were 
sacrificed at different times from 2 to 4 weeks post-injection, according to 
the cell line originally injected. Hematoxylin and eosin staining were 
performed on 5 mm-thick paraffin sections.  
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3.2 Molecular Biology 
3.2.1 Cloning  
The coding sequence of PRC2 members and c-Myc was amplified from 
total cDNA of hES cells (was kindly provided by Salvatore Oliviero), using 
primers designed to contain appropriate restriction enzymes (Appendix A).  
The PCR was assembled as described in Table 2.3 using the AccuPrime 
Pfx kit (Invitrogen) for its high fidelity. The cycling is shown in table 2.4. 
Reagent Final concentration 
AccuPrime Pfx Reaction mix 1x 
Primer forward 0.2 µM 
Primer reverse 0.2 µM 
Template 10-100 ng 
AccuPrime Pfx DNA Polymerase 1 u 
H2O to 50 µl 
Table 3.3 Reaction setup for the PCR amplification 
 
 
 
Temperature Time Cycling 
95°C 2 min 1x 
95°C 
55-64°C 
68°C 
15 sec 
30 sec 
1 min per Kb 
30 cycles 
68°C 2 min 1x 
4°C Cooling 
Table 3.4 Cycling conditions for the PCR amplification 
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The PCR reactions were then loaded into a 1% Agarose gel containing 0.5 
µg/ml ethidium bromide (made with TAE buffer). After sufficient resolution 
was achieved, the DNA fragments were visualized using a UV 
transilluminator (UVITEC, Cambridge) and the relevant pieces of DNA were 
excised and recovered using the Wizard SVGel Clean-Up system 
(Promega, cat. N°A9282), according to manufacturer’s instructions. 
Concentrations of PCR products were measured using NanoDrop 
spectrophotometer (Thermo Scientific).  
Digestion of the purified products and the vector backbone were performed 
for 2h at 37°C with appropriate enzymes (NEB) (Table 2.5). Subsequently, 
the vector was dephosphorylated by incubating the reaction with 1 unit of 
calf alkaline phosphatase (NEB, ) for 1h at 37°C. The PCR fragment and 
the vector were then once more purified using Wizard and their 
concentrations were measured using a NanoDrop spectrophotometer. 
 
 
Reagent Final amount 
10x Buffer NEB 1x 
Enzymes  4 u per µg of DNA 
DNA 2 µg 
ddH2O to 20 µl 
Table 3.5 Setup of the restriction digestion reaction 
 
Generally, ligations were performed using two different ratio of insert DNA 
to vector (Table 2.6) at 16°C overnight. A control reaction, using water 
instead of insert, was also performed. E. coli chemical competent bacteria 
(generated from the DB1035 bacteria as described in Molecular cloning: a 
laboratory manula) were transformed with 5 µl of each ligation reaction. 
Briefly the bacteria were incubated with DNA for 30 min on ice, the heat-
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shock at 42°C for 2 min and on ice for 2 min was performed. Then the 
bacteria were incubated in 200 µl of 2xYT medium at 37°C for 1h and 
plated on LB plates with 50 µg/ml Kanamycin (Sigma, cat. N°K1377). 
 
Reagent Ratio 1:1 Ratio 1:3 negative 
vector 100 ng 100 ng 100 ng 
Insert 100 ng 300 ng - 
T4 buffer (10x) 2 µl 2 µl 2 µl 
T4 ligase 1 µl 1 µl 1 µl 
H2O to 20 µl to 20 µl to 20 µl 
Table 3.6 Setup of the ligation reaction 
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 Figure 3.1 List of construct used in Fluorescence Resonance Energy Transfer 
(FRET).  
For each vector plasmid are shown the restriction sites used for cloning: (A) pECFP-EED. 
(B) pECFP-AEBP2. (C) pEYFP-MYC. (D) pEYFP-EZH2. (D) pEYFP-EED. 
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3.2.2 Gene transcription analysis 
3.2.2.1 RNA extraction 
For extraction of total RNA the cells were harvested by scrapping directly in 
the Trizol reagent (Ambion, cat. N°15596018) and lysed by pipetting. 200 µl 
of chloroform for each 1 ml of Trizol were added to the samples followed by 
vigorous shaking by hand for 15 sec and incubation for 2-3 min at RT. 
Phase separation was done by centrifugation at 12.000g for 15 min at 4°C 
and the water phase was transferred in a fresh eppendorf tube. Equal 
volume of isopropanol was added and the RNA was left to precipitate for 10 
min at RT. The RNA was recovered by centrifugation at 12.000g for 15 min 
at 4°C and washed with 75% ethanol. The RNA pellets were dried on a RT 
and resuspended in 30 µl RNAse free water. The concentration of RNA 
was measured using NanoDrop spectrophotometer. Moreover we analysed 
the 260/280 (Nucleic acid/Protein) and 260/230 (Nucleic 
acid/Polysaccharide) ratios per sample. Ratios, indicating the degree of 
nucleic acid purification, should be in a range of 1.8-2.1. 
 
3.2.2.2 Quantitative real-time PCR (qPCR) 
qPCR is a technique based on the general standard PCR principle, but 
using different fluorescent dyes and detection methods with better 
sensitivity. For the qPCR reaction we used SuperScript III One-Step SYBR 
Green kit (Invitrogen, cat. N° 11746). Briefly, 1 µl of each RNA or water (as 
negative control) was mixed with 19 µl of the primer-specific qPCR mix 
(Table 2.7) in the wells of a qPCR 96-well plate. The primer used to detach 
each gene product were designed using Universal ProbeLibrary Assay 
Design Center (Roche) and are listed in Appendix A. The amplification 
reaction was done using the StepOne Plus system (Applied Biosystem) 
and the cycling conditions are reported in Table 2.8. To ensure specificity 
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of amplification, melting curve analysis was performed. Relative gene 
expression levels were determined using calculated concentration values, 
normalized to ERCC Spike-In Control RNA (Ambion, cat. N°4456740). 
 
Component Final concentration 
SuperScript III RT Taq Mix 1 µl 
2X SYBR Green Reaction Mix 25 µl 
Forward primer, 10 µ l 1 µl 
Reverse primer, 10 µ l 1 µl 
Total RNA 1 µl 
H2O to 20 µl 
Table 3.7 Reaction setup for the qPCR amplification 
 
Temperature Time Cycling 
50°C 
95°C 
15 min 
5 min 
1x 
95°C 
60°C 
15 sec 
30 sec 
40 cycles 
From 60°C to 95°C Melting curve 
Table 3.8 Cycling conditions for the qPCR amplification 
 
3.2.3 Chromatin Immunoprecipitation (ChIP) 
The following procedure is based on [Zippo et al., 2007]. Briefly, the cells to 
be used for chromatin immunoprecipitation (ChIP) were treated with a 
cross-linking reagent before they were harvested. To this end, 37% 
formaldehyde (Sigma, cat. N°F8775) was added to the medium for a final 
concentration of 1% for 10 min at RT. The formaldehyde was the quenched 
by addition of 125 mM glycine and incubation for 5 min at RT.  The fixed 
cells were subsequently washed twice with cold PBS, harvested by 
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scrapping in 1 ml cold PBS and centrifuged for 5 min at 1500g. Cell pellets 
were lysed in ice-cold ChIP buffer and incubated on ice for 10 min and 
nuclear pellets were obtained by centrifugation at 14000 g at 4°C for 10 
min. The nuclear pellet was washed with 1 ml ChIP buffer and 
resuspended in 300 µl of ChIP buffer per 106 cells. The chromosomal DNA 
was then sheared using BioRuptor waterbath sonicator (Diagenode) at high 
setting for 10 min. Samples were sonicated in pulse of 30 sec with 30 sec 
intervals. Following sonication, the samples were cleared by centrifugation 
at 15000g for 10 min at 4°C. 
For the immunoprecipitation of specific proteins on the chromatin, 100 µg 
of chromatin was used per IP and a 10% input sample was retained. The IP 
samples were adjusted to 500 µl and 2.5 µg of antibody was added. As a 
negative control rabbit unspecific IgG was used. Following addition of 
antibody, the samples were incubated on a rotating wheel at 4°C O/N. The 
next day, samples were cleared by centrifugation to remove unspecific 
complexes and the top of the samples was transferred to a new Eppendorf 
tube containing 20 µl Protein A/G beads pre-washed in ChIP buffer. 
Samples were incubated on a rotating wheel at 4°C for 3h. The beads were 
then centrifuged at 500g for 5 min at 4°C and washed three times with 1 ml 
of ChIP buffer for 10 min at 4°C. The antibody/protein/DNA complexes 
were eluted from the beads by adding 50 µl of Elution Buffer at RT and 
shaking on a vortexer for 15 min at highest speed. The input samples were 
included at this stage and adjusted to 100 µl with elution buffer. NaCl was 
added to a final concentration of 0.2 M and the samples were incubated at 
65°C O/N to reverse the cross-linking. Next, RNase A was added to a final 
concentration of 0.1 mg/ml and samples were incubated for 30 min at 
37°C. The relative enrichment for specific DNA sequences was determined 
by qPCR, as described in section 2.2.2.2 using a SYBR GreenER qPCR 
SuperMix (Invitrogen, cat. N°11762). 
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3.2.4 Microarray analysis 
BeadChip Arrays were scanned with HiScan Array Scanner (Illumina) using 
the iScan Control Software (Illumina). Genes and probes transcript levels 
were obtained from Illumina Intensity Data (.idat) files, applying quantile 
normalization and background subtraction implemented by the 
GenomeStudio Gene Expression Module v1.0 Software (Illumina). All 
experiments in each condition reported were performed on triplicate 
biological samples, except for the Eed knocked down ES grown in LIF 
withdrawal and in presence of 4-OHT, for which a single replicate was 
analyzed on the array. Cut-offs for up- and down-regulation of gene 
expression were set to 1.5 fold change threshold in all the analyses 
performed. 
Single microarray replicates were subjected to dendograms cluster analysis 
performed with the GenomeStudio Gene Expression Module v1.0 Software 
(Illumina), using Euclidean distance matrix. The top 200 genes up- or 
down-regulated in the comparison between LIF maintained ES and EpiSC 
were selected to generate a heatmap reporting a hierarchical clustering 
analysis of both genes and single microarray replicates (complete linkage, 
Euclidean distance matrix), using the TM4 MeV v4.9 software.  
Differentially expressed genes in the LIF- versus Myc-maintained ES 
comparison were checked for biological and functional enrichment using 
both Ingenuity Pathway Analysis (IPA, Qiagen Redwood City, 
www.qiagen.com/ingenuity) based online tool PANTHER Classification 
System. 
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3.3 Biochemistry 
3.3.1 Immunoblotting analysis 
3.3.1.1 Total protein extraction 
The cells were washed twice with cold PBS, harvested by scrapping in 1 ml 
cold PBS and centrifuged for 5 min at 1500g. Harvested cell pellets were 
lysed by the addition of 5X v/v ice-cold F-buffer. Lysing was allowed to 
proceed for 30 min on a rotating wheel at 4°C. The chromosomal binding 
proteins were then separated using BioRuptor waterbath sonicator 
(Diagenode) at low setting for 5 min. Samples were sonicated in pulse of 
30 sec with 30 sec intervals. Lysates were cleared by centrifugation for 10 
min at 15000g at 4°C and supernatant was collected on ice. 
The protein concentration of lysates was determined using PierceTM BCA 
Protein Assay Kit (Thermo Scientific, cat. N°23227), according to 
manufacturer’s instructions. The absorbance was measured at λ=595 using 
SAFAS spectrophotometer (SAFAS, Monaco). Values were compared to a 
standard curve obtained from the BSA dilution series. 
Protein fractionation was performed by using Subcellular Protein 
Fractionation Kit (Thermo Scientific, cat. N°78840) according to 
manufacturer’s instruction. 
 
3.3.1.2 Western Blot 
Generally, 20 µg of protein samples were prepared by adding 4X Bolt LDS 
Sample Buffer (Novex, cat. N°B0007) and 10X Bolt Sample Reducing 
Agent (Novex, cat. N°B0009) to a 1X final concentration and samples were 
adjusted to an equivalent final volume by using ddH2O. The samples were 
then boiled at 95°C for 10 min. SeeBlue Plus 2 (Invitrogen, cat. N°LC5925) 
markers were used for monitoring fractionation and size estimation. For 
separating the samples the Novex system (life technologies) was used and 
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the samples were loaded onto a pre-cast Bolt 4-12% Bis-Tris Plus gels 
(Novex, cat. N°NW04122BOX) and run in Bolt MES running buffer (Novex, 
cat. N°B0002). Electrophoresis was performed at 110 V until desired 
fractionation was achieved. 
 
3.3.1.3 Immunoblotting 
After separation by electrophoresis, proteins were transferred to a 
nitrocellulose membrane (novex, cat. N°IB301001) using the iBlot transfer 
system (life technologies). Proteins were transferred at a 300 V for 7 min. 
Following this, the membrane was blocked in freshly prepared WB blocking 
buffer for 1 h at RT with constant agitation. The primary antibody commonly 
used in this work are listed in Appendix B. Generally, the primary 
antibodies were diluted at 1:1000 in WB blocking buffer and used for 
incubation of the membrane ON at 4°C with agitation. The membrane was 
then washed three times with WB washing buffer, each time for 5 min. 
Depending on the primary antibody used, the membrane was incubated 
with secondary antibody HRP-conjugated diluted in WB blocking buffer for 
1 h at RT (Appendix B). Following this incubation, the membrane was 
washed again three times for 5 min in WB washing buffer and then 
incubated with a 1:1 mix of ECL reagents (GE Healthcare, cat. 
N°RPN2232) for 5 min to initiate the chemiluminescence of HRP. The 
chemiluminescent signal was captured using LAS3000 system (GE 
Healthcare). 
 
3.3.2 Immunofluorescence 
ES cells were grown on a coverslip coated with 0.1% gelatin in a 24 well 
plate. The culture medium was removed carefully from the wells and cells 
fixed in 4% PFA for 20 min at RT. Subsequently the coverslips were 
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washed twice with PBS and permeabilized with IF permeabilization buffer 
for 10 min at RT. After permeabilization the coverslips were washed three 
times with PBS and blocked with IF blocking buffer for 30 min at RT. The 
primary antibody was diluted in IF blocking buffer (Appendix B) and a 
minimum of 150 µl was applied on cells. Following incubation at RT for 2 h, 
cells were washed three times with IF washing buffer and incubated for 1 h 
at RT with the secondary antibody diluted in IF blocking buffer. Finally, after 
three washes in IF washing buffer, the nuclei were counterstained with 
DAPI in PBS for 10 min at RT. The coverslips were carefully lifted from the 
well using fine tweezers and mounted on microscope slides using ProLong 
antifade medium (Invitrogen). 
Proximity ligation assay was performed using in situ PLA Technology (O-
link Bioscence) according to manufacturer’s instruction.  
Images were acquired using a Leica TCS SP5 confocal microscope with 
HCX PL APO 63x/1.40 objective. The data were analysed using Volocity 
software (). 
 
3.3.4 Fluorescence Resonance Energy Transfer (FRET) 
The technique of FRET permits to determine the interaction between two 
molecules within several nanometers in a cellular context. The mechanism 
of FRET involves a donor fluorophore in an excited electron state, which 
may transfer its energy to an acceptor group through a non-radiative 
process. The distance over which energy can be transferred is dependent 
on the spectral characteristic of the fluorophores, but is generally in the 
range 10-100A°.   
Briefly, NIH3T3 cells were transfected with the appropriate ratio between 
the fluorescence tagged proteins to optimize protein distribution. Myc-
interaction experiments were performed by co-expressing the MAX protein 
(Myc:Max ratio 4:1) and the protein of interest. FRET acceptor 
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photobleaching was carried out using the Leica TCS SP5 confocal 
microscope and apFRET software (Leica) according to the manufacturer’s 
instructions. Fixed cells were analysed with a HCX PL APO lbd.BL 
63.0x1.40 oil objective and 8x zoom. The argon laser was tuned to 458 nm 
to excite CFP (PMT window 465-495nm) and to 514 nm to excite YFP 
(PMT window 555-630 nm). The region of interest was bleached until 
intensity of 20% in the YFP channel using the 514 argon laser line. 
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3.4 Solutions 	  
Bacterial culture 
 
Luria broth (LB)   1% (w/v) NaCl 
     0.5% (w/v) yeast extract 
     1% (w/v) bacto-tryptone 
 
SOC medium    2% (w/v) tryptone 
     0.05% (w/v) yeast extract 
     0.006% (w/v) NaCl 
     0.002% (w/v) KCl 
     0.002% (w/v) MgCl2 
     0.036% (w/v) D-glucose 
 
 
Cell culture 
 
2x HBS    140 mM NaCl 
     1.5 mM Na2PO4 
     50 mM HEPES (pH 7.1) 
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Biochemistry 
 
F-buffer    10 mM HEPES 
     50 mM KCl 
     50 mM NaF 
     5 µM ZnCl2 
     0.1 mM Na3VO4 
     1% Triton X-100 
     10 mM Sodium butyrate 
     1x Anti-protease 
     1x Anti-phosphatase 
     1 mM PMSF 
 
WB washing buffer   PBS 
     0.1% (v/v) Tween-20 
 
WB blocking buffer   WB washing buffer 
5% dried milk (BIO-RAD, cat. N°170-
6404) 
 
IF permeabilization buffer  PBS 
     0.1% Triton X-100 
 
IF washing buffer   PBS 
     0.1% Tween-20 
 
IF blocking buffer   IF washing buffer 
     5% BSA 
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Immunoprecipitation 
 
ChIP buffer    50 mM HEPES pH 7.9 
     140 mM NaCl 
     1 mM EDTA 
     1% (v/v) Triton X-100 
     0.1% DOC 
     0.1% SDS 
     1 mM PMSF 
     1x anti-protease 
 
ChIP elution buffer   50 mM TrisHCl pH 8 
     1 mM EDTA 
     5 mM DTT 
     1% SDS 
 
 
DNA analysis 
 
TAE buffer    40 mM Tris Base 
     20 mM Acetic acid 
     1 mM EDTA 
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4. RESULTS 
4.1 c-Myc sustains self-renewal and pluripotency of ES 
Cells 
4.1.1 Enforced expression of c-Myc sustains ES cells self-
renewal 
In order to evaluate the ability of c-Myc to sustain ES cells self-renewal, we 
used ES MycT58AER cells (line R1) [Cartwright et al., 2005], which express 
an exogenous MycER fusion protein activated by 4-hydroxytamoxifen (4-
OHT) induction. This tool has the potential to monitor the kinetics of action 
of c-Myc activation through 4-hydroxytamoxifen (4-OHT) induction. In fact, 
the carboxyl terminus of MycER protein is fused to the ligand-binding 
domain of a mutant estrogen receptor (ER)  [Danielian et al., 1993]. It is 
constitutively expressed, but remains inactive until the 4-OHT is supplied. 
Moreover, the T58A mutation prevents c-Myc phosphorylation and 
subsequent ubiquitination, therefore extending the half-life of c-Myc.	  
Then, we compared ES cells grown in medium containing LIF or in a Myc-
dependent manner, in absence of LIF and with 4-OHT induction (Myc-
maintained) (Figure 4.1A). Colony morphology and alkaline phosphatase 
(AP) activity were used as initial readouts for ES cell maintenance. In 
agreement with previous studies [Cartwright et al., 2005], we show that 
activation of MycER is sufficient for the cells to grow with an uniform dome-
shaped colony morphology and elevated alkaline phosphatase activity 
(AP+) for the first three days (Figure 4.1B). On the contrary, cells grown in 
absence of LIF and 4-OHT, showed evident signs of differentiation and a 
dramatic reduction of AP+ colonies (Figure 4.1B).  Moreover, Myc-
dependent cells maintained the same efficiency in giving rise to round and 
AP+ colony in a single cell clonogenic assay, similar to LIF-maintained cells 
(Figure 4.1C). To exclude that 4-OHT treatment could affect their 
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stemness, we treated ES cells without MycER transgene with tamoxifen for 
three days. As shown in Figure 4.1D, we observed that without MycER 
activity ES cells were unable to proliferate and self-renew. These data 
suggest the specific role of c-Myc to sustain ES cells self-renewal, and this 
is not due to an exchange of growth factor secreted from the colonies, as 
the Myc-dependent cells were able to proliferate even when grown as 
single cells. 
 
 
Figure 4.1 c-Myc sustains self-renewal of ES cells.  
(A) Schematic representation of the experimental outline. (B) AP staining of ES cells MycER 
grown for three days in the indicated conditions and relative quantification of positive 
colonies are represented as percentage of the total colonies formed. Scale bar = 200 µm. 
(C) Single-cell clonogenic assay was performed and the relative number of colonies grown 
was quantified. (D) AP staining of R1 clone and relative quantification of positive colonies. 
Error bars represent standard deviation from 3 independent experiments. *p<0.05. 
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4.1.2 ES cells grown in a Myc-dependent manner maintain stem 
identity 
Among several biological activities regulated by c-Myc, it plays a major role 
in the control of the cell cycle and cell proliferation [Ponzielli et al., 2005; 
Meyer and Penn, 2008]. In order to show that enforced expression of c-Myc 
does not affect the proliferation of ES cells, cells number was recorded at 
24, 48 and 72h. The resulting growth curves demonstrated a comparable 
proliferation between LIF- and Myc-maintained ES cells, whereas cells 
grown without LIF and 4-OHT showed a reduction in proliferation (Figure 
4.2A). Moreover, doubling time analysis confirmed previous results, 
showing a similar time of divisions between Myc- and LIF-maintained ES 
cells and increased time for –LIF ES cells (Figure 4.2B).  
 
 
 
Figure 4.2 c-Myc maintains the proliferation of ES cells.  
(A) Growth curve of ES cells MycER grown in LIF-, Myc- and –LIF-dependency for three 
days. (B) Quantification of the doubling time of MycER ES cells maintained in presence of 4-
OHT, LIF or in absence of both LIF and 4-OHT. Error bars represent standard deviation 
from 3 independent experiments. **p<0.01. 
 
 
Single-cell tracking analyses confirmed that the LIF- and Myc-maintained 
ES cells have the same time of division. This analysis, suggests that Myc-
dependent ES cells maintain a symmetrical pattern of cell division, 
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requirement of pluripotency (Figure 4.3A). Finally, FACS (Fluorescence 
Activated Cell Sorting) cell cycle analysis of the cells after three days of 4-
OHT induction showed a cycle profiling comparable with that of cells grown 
in LIF containing media (Figure 4.3B).  
Taken together, these data suggest that enforced expression of c-Myc not 
only is sufficient to sustain ES cells self-renewal, but also is able to 
maintain a stem cell identity similar to that of standard conditions, 
circumventing LIF/STAT3 signal. 
 
 
 
Figure 4.3 c-Myc sustains pluripotency of ES cells.  
(A) Single-cell tracking of ES cells expressing H2B-eGFP. Lineage tree represent the 
pattern and timing of cell division of a single ES cell. (B) Cell cycle profile analysis to identify 
and quantify the different cell cycle phases: 1: Apoptotic cells (subG1); 2: G1; 3: S; 4: G2. 
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4.1.3 c-Myc activates an alternative regulatory circuit 
To understand the molecular mechanisms through which c-Myc can 
support ES cells identity, we performed gene expression profile analyses of 
Myc- and LIF-ES cells, together with Epiblast Stem Cells (EpiSC), inserted 
as a control for a primed state of stemness. This analysis revealed that, in 
terms of gene expression profile, Myc-maintained ES cells clustered 
together with LIF-dependent ES cells and were distant from EpiSC. Despite 
the observed similarities, a specific gene expression signature 
distinguished the Myc- from the LIF-ES cells (Figure 4.4A). We 
experimentally validated this conclusion showing that Myc- and LIF-ES 
cells expressed high levels of pluripotency-specific markers and low levels 
of EpiSC-specific markers, when compared to EpiSC (Figure 4.4B). In 
order to gain insights on which geneset were differentially regulated by c-
Myc, we interrogated Ingenuity Pathway Analysis (IPA), which indicated 
that ES cells pluripotency genes were enriched among the c-Myc up-
regulated genes (Figure 4.5A). Subsequently, we retrieved an independent 
list of pluripotency-associated genes, represented by the 
Oct4/Sox2/Nanog/Tcf3 co-bound targets [Marson et al., 2008] and 
performed Gene Set Enrichment Analysis (GSEA). In accordance with IPA, 
GSEA suggests a relative enrichment of this geneset in Myc- with respect 
to LIF-maintained ES cells (Figure 4.5A). Altogether, these multiple 
bioinformatical approaches indicate that c-Myc potentiates pluripotency-
associated genes in ES cells.  
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Figure 4.4 Myc ES cells maintain naïve pluripotent state.  
(A) Heat map of the most differentially expressed genes (cut-off >1.5 fold change, 200 
genes) between LIF-maintained ES cells and EpiSC. (B) The relative transcriptional level of 
some of ES cells and EpiSC specific genes were confirmed by qRT-PCR analysis in the 
indicated conditions. Error bars represent standard deviation from 3 independent 
experiments. *p<0.05; **p<0.01. 
 
 
In order to assess whether Myc-maintained ES cells maintained their 
stemness identity, we analysed the core of TRN, Oct4, Sox2 and Nanog. 
To measure the level of TRN in Myc-dependent cells, a qPCR analysis of 
Oct4, Sox2 and Nanog mRNA was performed. The analysis showed that 
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expression levels of Oct4 and Sox2 were similar in LIF- and Myc-
maintained ES cells; on the contrary, mRNA of Nanog decreased in Myc-
maintained ES cells (Figure 4.5B). The observed reduction of Nanog at 
transcriptional and protein level, could be explained by the fact that Nanog 
is a downstream target of LIF/STAT3 pathway [Niwa et al., 2009]. 
Furthermore, a subset of pluripotency transcriptional regulators including 
Dppa3, Utf1, Nr0b1 and c-Myc [MacArthur et al., 2012] were 
transcriptionally up-regulated in Myc-maintained ES cells (Figure 5B). 
Taken together, this results indicate that c-Myc maintains ES cells identity 
by reinforcing a LIF-independent alternative core regulatory transcription 
circuit. 
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Figure 4.5 c-Myc activates an alternative pathway.  
(A) Ingenuity Pathway Analysis (IPA) of differentially regulated genes between LIF- and 
Myc-maintained ES cells (n=3). (B) The relative transcriptional levels of some of the 
pluripotency genes were confirmed by qRT-PCR analysis in the indicated conditions. Error 
bars represent standard deviation from 3 independent experiments. *p<0.05; **p<0.01; 
***p<0.001. 
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4.1.4 c-Myc potentiates Wnt pathway 
Among the up-regulated pathway in Myc-maintained ES cells, we found the 
Wnt/β-Catenin signalling (Figure 4-5A). As recent works shown that Wnt 
signalling stimulate self-renewal and prevent ES cells differentiation [ten 
Berge et al., 2011; Merrill, 2012], we hypothesized that c-Myc can 
potentiate the Wnt/β-Catenin signalling to sustain ES cell identity. In order 
to understand how c-Myc sustains the Wnt pathway, we first performed 
protein level analysis, showing that Myc-dependent potentiation occurs at 
multiple stages (Figure 4.6A). At the cell membrane level, we observed 
activation of the Fzd/Lrp6 receptor complex resulting in the increased 
phosphorylation of Lrp6 in Myc-maintained ES cells. At the level of the 
destruction complex, which promotes β-Catenin degradation, we registered 
reduction of the rate-limiting factor of the complex Axin1. At the level of the 
nucleus we observe that the co-factors of Wnt pathway (Tcf and Lef family 
members) were up-regulated. Furthermore, in Myc-maintained ES cells we 
found an increased level of phosphorylation of Akt. The phosphorylation of 
Akt at Ser473 is believed to phosphorylate and inhibit Gsk3β [Cohen and 
Frame 2001], suggesting that c-Myc could potentiate Wnt pathway (Figure 
4.6B). To further analyse the potentiation of Wnt pathway and to obtain 
insight into the mechanism of action of c-Myc, we performed qPCR 
analysis to measure the transcriptional level of members of Wnt pathway. 
The analysis showed that genes coding for receptors and co-receptors (Lrp 
and Fzd member family) are transcriptionally up-regulated; on the contrary 
genes coding for antagonists, such as Dkk1 and Sfrp1, are down-regulated 
in Myc-maintained ES cells (Figure 4.6C). 
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Figure 4.6 c-Myc activates Wnt/β-Catenin signalling.  
(A) Western Blot analysis of Wnt/β-Catenin signaling pathway related proteins and (B) 
Western Blot analysis of Akt/Gsk3β pathway related proteins. Total protein extracts were 
collected from LIF and Myc-maintained ES cells, and immunostaining analysis was 
performed using the indicated antibodies; β-Actin was used as loading control. (C) The 
relative transcriptional level of some of the Wnt pathway associated genes was confirmed 
by qRT-PCR analysis in the indicated conditions. Error bars represent standard deviation 
from 3 independent experiments. *p<0.05; **p<0.01; ***p<0.001. 
 
 
Since we observed that the destruction complex was inhibited in Myc-
maintained ES cells, resulting in increased active β-Catenin, we 
hypothesized that it could move into the nucleus to activate the 
transcription of Wnt pathway target genes. To address this point, we 
measured the activity of Wnt pathway in Myc-maintained ES cells using 
Proximity Ligation Assay (PLA) method, that allows to detect and localize 
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direct protein interactions with a single molecule resolution. The results of 
PLA showed an increased translocation of β-Catenin into the nucleus and 
its association with downstream effectors Tcf1 and Tcf3 in Myc-maintained 
ES cells (Figure 4.7), suggesting that Myc-activated Wnt pathway could 
potentiate the transcriptional expression of Wnt target genes. Taken 
together, these data suggest that enforced c-Myc activity could reinforce 
the Wnt/β-Catenin signalling by repressing the antagonists of the pathway 
and preventing β-Catenin degradation through inhibition of destruction 
complex. 
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Figure 4.7 β-Catenin translocates in the nucleus and activates the expression of its 
target genes in Myc-maintained ES cells.	  	  	  
In situ Proximity Ligation assay (PLA) was performed to measure the proximity between 
Tcf1 or Tcf3 and β-Catenin within cell nuclei of LIF- and Myc-maintained ES cells. 
Representative images of PLA between Tcf1 or Tcf3  and β-Catenin within cell nuclei of LIF- 
and Myc-maintained ES cells and relative quantification; scale bar = 50 µm. 
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4.1.5 Wnt pathway activity is essential to sustain ES cell identity 
in Myc-maintained ES cells 
The main negative regulators of Wnt pathway are the antagonists Dkk1 and 
Sfrp family member, which prevent the activation of the pathway by 
interfering with the receptor-ligand interaction. We hypothesized that Myc-
maintained condition preserves the ES cell status by repression of Wnt 
antagonist. To test this hypothesis, we treated Myc-maintained ES cells 
with soluble Wnt inhibitors in order to complement their down-regulation. 
Upon Dkk1/Sfrp1 treatment, we found a change in cell morphology and a 
relative reduction of AP+ cells (Figure 4-8), indicating that a reduction of 
Wnt pathway activity is sufficient to start differentiation in Myc-maintained 
ES cells. Importantly, these effects were counteracted by ES cells 
stimulation with soluble Wnt3a (Figure 4.8).  
 
 
 
 
Figure 4.8 c-Myc requires active Wnt pathway to sustain ES cells self-renewal.  
Alkaline Phosphatase (AP) staining of R1 ES MycER cells grown for three days in presence 
or absence of Wnt pathway inhibitors Dkk1 and Sfrp1 or the Wnt3a ligand, as indicated. 
Relative quantification of positive colonies is represented as percentage of the total colonies 
formed. Representative images of stained ES cells are shown. Scale bar = 200 µm. Error 
bars represent standard deviation from 3 independent experiments. **p<0.01; ***p<0.001. 
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Next, we evaluate whether c-Myc requires β-Catenin, the downstream 
effector of Wnt signalling, to sustain self-renewal in ES cells. To address 
this point, we generated a MycER β-Catenin knocked-down ES cells clone 
(shβ-Catenin ES cells), and we observed that it did not perturb self-renewal 
of ES cells grown in presence of LIF (Figure 4-9). In contrast, shβ-Catenin 
ES cells grown without LIF in presence of 4-OHT, started to differentiate, 
despite c-Myc was enforced, as shown by the changed colony morphology 
and the reduced number of AP+ colonies (Figure 4-9). Differently from what 
measured upon Dkk1 and Sfrp1 treatment, exogenous Wnt3a stimulation 
cannot revert the phenotype of Myc-maintained ES cells knockdown for β-
Catenin (Figure 4.9). 
Taken together, these data suggest that c-Myc, in order to exert its function 
on ES cells maintenance, requires the intact Wnt/ β-Catenin signalling. 
 
 
 
 
Figure 4.9 Active β-Catenin is essential in Myc-maintained ES cells.  
AP staining of MycER ES cells clones expressing either a control shRNA (shCtrl) or a β-
Catenin shRNAs (shβ−Cat) and grown for three days in the indicated conditions; relative 
quantification of positive colonies are represented as percentage of the total colonies 
formed. Representative images of stained ES cells grown in the different conditions are 
shown. Scale bar = 200 µm. Error bars represent standard deviation from 3 independent 
experiments. **p<0.01; ***p<0.001. 
  
	   65 
4.1.6 c-Myc directly associates with PRC2 
In a previous work we showed that c-Myc is able to directly interact with the 
chromatin modifier Polycomb Repressive Complex 2 (PRC2), in vitro. Since 
the genes antagonists of the Wnt pathway such as Dkk and Sfrp family 
members are bivalent genes [Bernstein et al., 2006; Kurimoto et al., 2015] 
and Polycomb targets in ES cells [Leeb et al., 2010], we hypothesized that 
c-Myc could mediate the recruitment of PRC2 complex at their promoter in 
order to cause their repression. First of all, we confirmed that c-Myc directly 
interacts with PRC2 also in the cellular context. To assess this point, we 
used acceptor photobleaching Fluorescence Resonance Energy Transfer 
(apFRET). We cloned Eed and Aebp2 cDNA, which direct interact with c-
Myc in vitro, in expression vectors that carried the fluorescent protein CFP 
(as described in methods). c-Myc cDNA instead was cloned in expression 
vector that carried the fluorescent protein YFP (Figure 3.1). Since we 
observed a low efficiency of co-transfection in mES cells, we performed this 
analysis in HEK 3T3 cells. To measure the fret efficiency we followed the 
protocol described in chapter 3.3.4. To analyse the association between 
Eed and c-Myc we used as positive control a construct expressing Ezh2 
fused with YFP (Figure 3.1), while as negative control a construct 
expressing only YFP. apFRET results showed that EED is able to bound c-
Myc also in vivo (Figure 4.10A).  
Previous works suggest that Aebp2 interacts with Eed in PRC2 complex 
[Ciferri et al., 2012], then to quantify the association between Aebp2 and c-
Myc, we used a construct expressing Eed fused with CFP as positive 
control. The results showed that Aebp2 directly interacted with c-MYC with 
high efficiency (Figure 4.10B). Furthermore, we tried to understand through 
which domain c-Myc could interact with Eed and Aebp2. Since Myc 
homology Box II (MBII) is involved in several interactions with a wide range 
of co-factors of c-Myc, essential for c-Myc activity, we cloned c-Myc protein 
deleted in the MBII domain (MycΔMBII) fused with YFP and we used the 
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same strategy to quantify association with EED and AEBP2. The results 
showed that the deletion of the MBII domain resulted in a reduction of the 
interaction with both EED and AEBP2 (Figure 4.10). These results suggest 
that c-Myc directly interacts with PRC2 in a cellular context and that its 
MBII domain is required for an efficient binding to the complex. 
 
 
 
 
Figure 4.10 FRET efficiency. 
The Fluorescence Resonance Energy Transfer (FRET) efficiency between Eed- or Aebp2-
CFP and the indicated YFP-fusion proteins was calculated and the data are represented as 
the mean and the relative standard deviation obtained by analyzing 12 samples in three 
independent biological replicas. **p<0.01. 
 
  
	   67 
4.1.7 c-Myc requires PRC2 complex to repress Wnt pathway 
antagonists 
To investigate whether Myc-PRC2 interaction was essential to sustain self-
renewal in Myc-maintained ES cells, we generated stable MycER clones 
transduced with lentiviral vectors expressing Eed (shEed) or Ezh2 (shEzh2) 
short hairpin RNA. First, the knockdown efficiency of the shRNAs was 
determined measuring the protein level of Eed and Ezh2 in LIF- and Myc-
maintained cells. Both the shRNAs had a good knockdown efficiency, as a 
reduction of Eed and Ezh2 protein levels was observed (Figure 4.12); in 
addition, in both knockdowns we observed a reduction of Suz12, confirming 
the inhibition of PRC2 complex (Figure 4.11).  
 
 
 
Figure 4.11 Eed and Ezh2 protein levels after knockdown.  
ES cells were transduced with shRNAs against Eed and Ezh2 and 72h later PRC2 proteins 
levels were quantified by Western Blot. 
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Thereafter, we analyzed the capacity of Eed and Ezh2 knockdown-MycER 
cells to self renew in either a LIF-supplemented medium or in Myc-
dependency. We observed that although c-Myc was enforced, in the 
absence of the PRC2 complex, ES cells started to differentiate, as shown 
by the changed morphology of the colonies and the reduced number of 
AP+ colonies (Figure 4.12) in both Eed and Ezh2 knockdown-cells. To 
evaluate whether the activation of Wnt pathway is a downstream effect of 
the interaction between c-Myc and PCR2 complex, we treated the Eed and 
Ezh2 knockdown-cells with recombinant Wnt3a. When Wnt/β-Catenin 
signalling was reactivated, Myc-maintained ES cells self-renewal was 
restored, as shown by the increased number of AP+ colonies (Figure 4.12). 
On the contrary, Dkk1/Sfrp1 supplementation even increased the negative 
effect of PRC2 knocking-down on Myc-dependent self-renewal capacity of 
ES cells (Figure 4.12).  
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Figure 4.12	  ES cells self-renewal upon Eed and Ezh2 knockdown.  
AP staining of MycER ES cells clone expressing either a control shRNA (shCtrl), Eed 
shRNAs (shEed) or Ezh2 shRNAs (shEzh2) and grown for three days in the indicated 
conditions; relative quantification of positive colonies are represented as percentage of the 
total colonies formed. Representative images of stained ES cells grown in the different 
conditions are shown. Scale bar = 200 µm. Error bars represent standard deviation from 3 
independent experiments. *p<0.05; **p<0.01; ***p<0.001. 
 
 
To evaluate the effect of the interaction between c-Myc and PRC2, we 
performed Chromatin Immunoprecipitation (ChIP) experiments. To this end, 
we generated endogenous c- and N-Myc double Knocked-down in MycER 
ES cells (dKD), by transducing them with lentiviral vectors expressing 
either c- and N-Myc short hairpin RNAs. The established ES cells clone 
allowed the modulation of MycER protein level. Indeed, nuclear/cytoplasm 
fractionation showed that 16h after 4-OHT removal, MycER was completely 
export outside the nucleus and accumulated in the cytoplasm (Figure 4.13).  
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Figure 4.13 c-Myc protein levels after knockdown.  
ES cells were transduced with shRNAs against c-Myc and N-Myc and 72h later 
nuclear/cytoplasm fractionation were performed and c-Myc proteins levels were quantified 
by Western Blot. Lamin B1 and Tubulin were used as loading control for nuclear and 
cytosolic fractionation respectively.  
 
 
ChiP experiments showed that 16h after 4-OHT withdrawal, the loss of c-
Myc binding led to reduction of H3K27me3 and Suz12 levels on Dkk1 and 
Sfrp1 promoters (Figure 4.14), while the levels of H3K4me3 were not 
affected. To evaluate that c-Myc directly recruits PRC2 on the promoters, 
after 16h without 4-OHT, we re-treated the ES cells with 4-OHT for 4h, and 
we observed an increase of Suz12 and H3K27me3 levels on the Dkk1 and 
Srp1 promoter. These results indicate that c-Myc could potentiate the Wnt 
pathway through PRC2 recruitment on Wnt antagonist promoter, therefore 
mediating their silencing.  
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Figure 4.14 Binding of PRC2 and relative H3K27me3 histone mark on Dkk1 and Sfrp1 
promoter.  
Chromatin immunoprecipitation of PRC2 and H3K27me3 on the Dkk1 and Sfrp1 TSS in ES 
cells c-Myc/N-Myc (dKD) Knockdown. The shCtrl and the dKD ES cells were maintained 
respectively in LIF (black line) or in LIF in presence of 4-OHT (red line). After 56 h the dKD 
ES cells were either grown in the same conditions (+4-OHT, red line) or shifted to LIF only (-
OHT, blu line) medium for the following 16 hours. Thereafter, the MycER protein was 
reactivated upon four hours treatment with 4-OHT (-/+ 4-OHT, green line). 
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4.2 c-Myc establishes an epigenetic memory in ES cells by 
generating a self-reinforcing positive feedback loop 
4.2.1 c-Myc sustains ES cells self-renewal in long-term culture 
We extended our analysis by assessing c-Myc ability to sustain ES cell 
self-renewal in long-term culture. To address this issue, we completely 
removed the LIF from the culture media and maintained ES cells only in the 
presence of MycER induction (Figure 4.15A). In agreement with a previous 
work [Cartwright et al., 2005], even after several passages in 4-OHT 
stimulation, Es cells maintained their identity, as shown by the number of 
AP+ colonies respect to LIF grown cells. Moreover Myc-maintained ES 
cells could proliferate indefinetly (Figure 4.15B). These results suggest that 
MycER activation can replace LIF activity in the long-term maintenance of 
ES cells. 
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Figure 4.15 c-Myc sustains ES cells self-renewal in long-term culture.  
(A) Schematic representation of the experimental outline. R1 MycER cells were grown either 
in presence of LIF (1000U/ml), as standard condition (named LIF, green line), or absence of 
LIF and in presence of 50 nM 4-OHT (named Myc, red line), or in absence of both LIF and 
4-OHT (named -Myc, light red line). (B) Long-term colony forming assay was performed 
culturing cells in presence of LIF or 4-OHT (Myc) and the relative quantification of AP 
positive colonies was assessed at the indicated passages, until 18 days. Error bars 
represent standard deviation from 3 independent experiments. *p<0.05. 
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4.2.2 c-Myc establishes an epigenetic memory in ES cells 
Environmental signals can induce changes in gene expression and 
chromatin structure. Such changes define cell identity and differentiation 
potential and can be maintained even in absence of initial signals, through 
many cell divisions [Bonasio et al., 2010]. We decided to test whether or 
not an environmental-induced epigenetic change could be heritable through 
mitosis. In order to test our hypothesis, we measured the self-renewal 
capacity of Myc-maintained ES cells following MycER inactivation upon 4-
OHT withdrawal from the culture medium (call Myc-derived cells, -Myc) 
(Figure 15.A). We observed that upon only 6 days of culture with 4-OHT, if 
the environmental stimulus was removed, the ES cells started to 
differentiate. On the contrary, after twelve days of 4-OHT induction, despite 
a slight reduction in the first passages after stimulus removal, the 
morphology and the number of AP+ colonies were similar in LIF-, Myc-
maintained and Myc-derived ES cells (Figure 4.16A). Furthermore, the rate 
of cellular proliferation shown that Myc-derived ES cells were able to 
expand indefinitely in the absence of both LIF and 4-OHT, yet maintaining 
their morphology (Figure 4.16B). 
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Figure 4.16 Myc-derived ES cells are able to self-renew and grow indefinitely.  
(A) ES cells were grown for six passages in Myc-dependency (+4-OHT) and then were 
maintained in either the same culture condition (Myc) or they were grown in absence of both 
4-OHT and LIF (-Myc). (B) Growth curve of LIF, Myc-maintained and Myc-derived ES cells. 
The relative quantification of AP positive colonies at each indicated passage were compared 
to ES cells grown in parallel in LIF-containing medium (LIF) and are represented as 
percentage of the total colonies formed. Representative images of stained ES cells at 
passages 9 and 16 are shown. Scale bar = 200 µm. Error bars represent standard deviation 
from 3 independent experiments. *p<0.05; **p<0.01. 
 
 
 
To confirm that Myc-derived ES cells maintained a stem identity, we 
performed cell cycle profile and analysis of the timing of cell divisions. 
FACS analysis of Myc-derived cells showed that cell cycle is similar to LIF- 
and Myc-maintained cells (Figure 4.17A), and also the timing of divisions 
were comparable to LIF or Myc-maintained ES cells (Figure 4.17B).  
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Figure 4.17 Cell cycle distribution and doubling time of ES cells upon 4-OHT 
withdrawal.  
(A) ES cells were growth in LIF, Myc or –Myc manner and 48h later fixed and subjected to 
FACS. (B) Quantification of the doubling time of MycERT58A ES cells maintained in presence 
of LIF, 4-OHT or in absence of both LIF and 4-OHT. 
 
 
Finally, single cell tracking analysis confirm that the reduction of colonies in 
Myc-derived cells is attributable to increased cell death, however this cells 
showed a symmetrical pattern of division, suggesting that they maintained 
their pluripotency (Figure 4.18).  
 
 
 
 
Figure 4.18 Single cell tracking analysis of LIF, Myc-maintained and Myc-derived ES 
cells expressing H2B-eGFP.  
Lineage tree represents the pattern and timing of cell division of a single Embryonic Stem 
Cell grown in the indicated conditions. 
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To exclude the possibility that even in absence of 4-OHT induction, active 
form of MycER could be present in the Myc-derived ES cells, we performed 
nuclear/cytoplasm fractionation and analysed the localization of MycER. 
Despite a small amount of MycER was still present in the nucleus of Myc-
derived cells at P7, this was completely absent in the subsequent passages 
(P8, P9 and P16) (Figure 4.19). 
 
 
 
Figure 4.19 MycER protein levels in Myc-derived ES cells.  
ES cells were harvested at different passages and nuclear/cytoplasm fractionation were 
performed and c-Myc proteins levels were quantified by Western Blot. Gapdh and histone 
H3 were used as loading control for cytosolic and nuclear fractionation respectively.  
 
 
Taken together these results indicate that c-Myc not only sustains self-
renewal in ES cells, but its prolonged over-expression induced by extern 
stimuli, can establish an epigenetic memory that would sustain ES cells 
self-renewal even in absence of further external stimuli. 
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4.2.3 The Myc-dependent epigenetic memory is not clone 
dependent 
To examine whether the ability of c-Myc to establish an epigenetic memory 
could be ES MycT58AER clone-dependent, we generated an independent 
ES cells clone, also expressing exogenous MycER (called A2 MycER 
clone) (Figure 4.20A). First of all, we investigated the cell pluripotency of 
MycER A2 clone, by measuring the protein levels of five genes implicated 
in pluripotency maintenance: Oct4, Nanog, Klf4, Sox2 and c-Myc (Figure 
4.20A). Then, we compared A2 MycER cells grown in LIF or with 4-OHT 
induction and we measured a same number of dome-shaped AP+ colonies 
(Figure Figure 4.20B). Furthermore, their rate of proliferation, timing of 
division and cell cycle profile were comparable to LIF or Myc-maintained 
ES cells (Figure 4.21). Then, we measured the capacity of c-Myc to 
establish an epigenetic memory in A2 MycER clone. The cells were grown 
in absence of LIF with 4-OHT induction for 6 passages, then the 4-OHT 
was removed from the culture medium. We observed that also in an 
independent clone, Myc-derived ES cells maintained the same efficiency to 
give rise to round and AP+ colony similar to LIF-ES cells (Figure 4.22). 
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Figure 4.20 Characterization of the independently derived MycER ES cells A2 clone. 
 (A) Protein extracts were obtained from the MycERT58A ES cells clone R1 and from the 
newly derived MycER clone A2, maintained in presence of 4-OHT. Immunoblot analysis was 
performed with the indicated antibodies to measure the relative protein levels. The arrow 
indicates the MycER fusion protein. β-Actin was used as loading control. (B) Alkaline 
Phosphatase (AP) staining of the MycER A2 clone ES cells grown for three days in the 
indicated conditions and relative quantification of positive colonies are represented as 
percentage of the total colonies formed. Representative images of stained ES cells 
maintained for three days in LIF, 4-OHT (Myc) or in -LIF (middle panels). Scale bar = 200 
µm. Error bars represent standard deviation from 3 independent experiments. *p<0.05; 
**p<0.01. 
 
 
 
Figure 4.21 Cell cycle, doubling time and cell proliferation of A2 MycER clone. 
Cell cycle profiles, doubling time and growth curve of A2 MycER clone. Error bars represent 
standard deviation from 3 independent experiments. **p<0.01.  
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Figure 4.22 Myc-derived established from A2 MycER clone. 
MycER A2 clone ES cells were grown for six passages in Myc-dependency (+4-OHT) and 
then were maintained for three more passages in either the same culture condition (+4-
OHT) or grown in absence of both 4-OHT and LIF (- Myc). The relative quantification of AP 
positive colonies at each passage were compared to ES cells grown in parallel in LIF 
conditions and are represented as percentage of the total colonies formed. Representative 
images of stained ES cells maintained for three days in LIF, 4-OHT (Myc) or in -LIF/-4-OHT 
(-Myc) (middle panels) and the relative cell cycle profiles (lower panels) are shown. Scale 
bar = 200 µm. Error bars represent standard deviation from 3 independent experiments. 
*p<0.05; **p<0.01. 
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4.2.4 Myc-derived ES cells maintained pluripotency 
Pluripotency is defined by the ability of cells to differentiate into derivatives 
of all the three embryonic germ layers: ectoderm, mesoderm and 
endoderm. A common tool to generate all three germ layers from ES cells 
in vitro is Embryoid Bodies (EBs) differentiation. To evaluate the 
differentiation potential of the Myc-derived ES cells we tried to aggregate 
Myc-derived ES cells in suspension, in order to form EBs. In this assay, the 
FBS was replaced by KnockOut Serum Replacement (KSR) to promote cell 
differentiation. In addition, we grew the cells into non-tissue culture-treated 
dishes to prevent their adherence to the plate. To examine the 
differentiation status of the cultured EBs, a qPCR analysis of lineage-
specific genes was performed at different time point. We observed a similar 
expression of neuroectoderm (Pax6), endoderm (Gata6) and mesoderm 
(Pecam1) specific markers between LIF-, Myc-maintained and Myc-derived 
ES cells at day 8 of EBs differentiation, indicating that those cells can give 
rise to different germ layers in vitro (Figure 4.23). 
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Figure 4.23 Embryoid bodies formation.  
(A) LIF-, Myc-maintained or Myc-derived (-Myc) ES cells were grown for nine passages and 
then differentiated by inducing the formation of Embryoid Bodies (EBs). Representative 
images of forming EBs at 4, 6 and 8 days are shown. Scale bar = 200 µm. (B) The relative 
transcriptional level of lineage-restricted genes were quantified by qRT-PCR analysis in the 
formed EBs. Error bars represent standard deviation from 3 independent experiments. 
*p<0.05; **p<0.01. 
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In order to further investigate Myc-derived ES cell pluripotency, we tried to 
mimick the EpiSC transition in vitro from ES cells. First of all, we had to 
adapt ES cells to grow in a serum-free medium containing a MAPK inhibitor 
(PD0325901) and GSK3 inhibitor (CHIR99021) (2i medium), since under 
this conditions they are known for exhibiting a more homogeneous cell 
populations respect to normal culture medium. Then we derived EpiSC-like 
cells (EpiLCs) by culturing ES cells for 3 days in N2B27 medium 
supplemented with Activin A, basic fibroblast growth factor (bFGF) and 
KSR. In those conditions we observed a uniform differentiation of ES cells 
into flattened epithelial colonies that mimicked the epiblast structure (Figure 
4.24).  
 
 
 
 
Figure 4.24 Epiblast-like cell transition.  
Work outline and bright-field images of EpiLC induction from LIF-maintained and Myc-
derived ES cells. EpiSC were used as control. Scal bar = 200 µm. 
 
 
In order to measure the EpiSC transition, we quantified the expression of 
EpiSCs specific genes in the EpiLCs at 3 different days of differentiation, 
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and we used EpiSCs as positive control. In agreement with previous results 
[Hayashi et al., 2011], the expression level analysis showed that both in 
LIF-maintained and in Myc-derived ES cells, the level of Oct4 did not 
change during EpiLC transition, whereas genes more associated with the 
naïve state, such as Sox2 and Klf2, were down-regulated, similarly to 
EpiSC.  Finally, during the transition, the expression level of genes 
associated with the primed state, such as Fgf5 and Dnmt3b were up-
regulated similarly to EpiSC (Figure 4.25). These results confirmed that 
Myc-derived ES cells retain their naïve pluripotent state. 
 
 
 
Figure 4.25 Gene expression profiles during EpiLC transition.  
mRNA at different time point was measured by qPCR. EpiSCs were used as control. For 
each gene examined, the ΔCT from the average CT values of the two independent 
housekeeping genes Actin and Gapdh was calculated. The value was set as 0. For each 
point, the average value from three experiments is shown on the log2 scale. 
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Most importantly, Myc-derived ES cells pluripotency was corroborated by 
the fact that they were able to form teratomas once injected in Nude mice 
(Figure 4.26A). Haematoxylin/Eosin staining showed mesodermal-, 
ectodermal- and endoderml-derived cells, demonstrating that Myc-derived 
ES cells are able to differentiate into the three germ layers in vivo, similarly 
to LIF and Myc-maintained ES cells [Cartwright et al., 2005] (Figure 4.26B). 
Taken together, these results suggest that Myc-derived ES cells maintain 
their pluripotency, as they are able to differentiate into the three germ 
layers both in vitro and in vivo. 
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Figure 4.26 Myc-derived ES cells form teratomas upon injected in nude mice.  
Teratoma assay assessing the pluripotency of LIF- (LIF), Myc-maintained (Myc) and Myc-
derived (-Myc) ES cells upon injection into Nude mice. (A)Animals were sacrificed 24 days 
after injections and the whole brain were removed to measure the presence and size of 
teratomas. Scale bar = 5 mm. (B) Haematoxylin/Eosin staining showed mesodermal- 
(mesenchymal-like; §), ectodermal- (epithelial-like; #) and endodermal-derived (gut-like; *) 
cell types in each teratoma. Scale bar = 200 µm.  
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4.2.7 c-Myc sustains a self-reinforcing positive feedback loop 
To evaluate the molecular mechanisms through which c-Myc could 
establish an epigenetic memory in ES cells, we investigated the Wnt 
pathway targets that could have a role on ES cells identity. To identify the 
downstream effectors of the Wnt pathway that are required for Myc-
dependent self-renewal maintenance, we crossed the geneset of 
pluripotency factors [Marks et al., 2012; MacArthur et al., 2012] with the 
Oct4/Sox2/Nanog and Tcf3 co-bound targets, and analysed their 
expression profile in Myc- versus LIF-maintained ES cells. We found that 
both the endogenous c- and N-Myc genes are downstream effectors of the 
Wnt pathway and that their regulation depends on the MycER-driven 
reinforcement of Wnt signalling (Figure 4.27A). In fact, treatment of Myc-
maintained ES cells with soluble Dkk1/Sfrp1 strongly inhibited the MycER-
dependent transcriptional activation of both c- an N-Myc.  
Thereafter, we evaluated whether endogenous Myc proteins are required to 
sustain Myc-dependent self-renewal capacity. In order to address this 
issue, we transduced MycER ES cells with lentivirus expressing inducible 
shRNA for both c- and N-Myc (called i-dKD), thus allowing us to tightly 
control the level and timing of gene silencing (Figure 4.27B). We observed 
that reduction of about 50% of the total amount of Myc proteins was 
sufficient to block the MycER-dependent self-renewing circuit in Myc- but 
not in LIF-maintained ES cells (Figure 4.27C). The role of endogenous Myc 
as downstream targets of the Wnt pathway was further highlighted by the 
finding that while control ES cells responded in a dose-dependent manner 
to Wnt3a-induced self-renewal, the Myc i-dKD cells did not. 
Taken together, these findings show that activation of MycER establishes a 
positive feedback loop by sustaining the Wnt signalling, which in turn 
triggers the transcriptional activation of the endogenous c- and N-Myc 
genes. This self-reinforcing circuit plays a pivotal role in maintaining the 
identity of Myc-dependent ES cells. 
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Figure 4.27 Myc sustains a self-reinforcing positive feedback loop.  
(A) The relative transcriptional level of endogenous c- and N-Myc was confirmed by qRT-
PCR analysis on RNAs extracted from ES cells grown in the indicated conditions for three 
days. (B) Western Blot analysis of proteins extracted from MycER ES cells expressing an 
IPTG-inducible control (shCtrl) or IPTG-inducible double c- and N-Myc shRNAs (dKD). 
Immunostaining (IB) analysis was performed using the indicated antibodies; β-Actin was 
used as loading control. (C) AP staining of MycER ES cell expressing either an IPTG-
inducible control (shCtrl) or an IPTG-inducible c-Myc and N-Myc shRNAs (dKD) and grown 
in the indicated conditions for three days; relative quantification of positive colonies are 
represented as percentage of the total colonies formed. Error bars represent standard 
deviation from 3 independent experiments. *p<0.05; **p<0.01.  
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4.2.8 Myc-derived cells acquire a PRC2-dependent epigenetic 
memory 
We asked whether the self-reinforcing regulatory circuit, triggered by 
prolonged MycER activation, could be maintained by the epigenetic 
silencing of Wnt antagonist through PRC2 recruitment. To assess this 
point, we treated ES cells with two different inhibitors of Ezh2 
methyltransferase activity, EPZ and GSK126, and in both cases we 
observed a strong reduction of dome-shaped and AP+ colonies (Figure 
4.28), suggesting that Myc-derived cells required an active PRC2 complex 
to self-renew. Importantly, the PRC2 inhibition could be reverted by treating 
the cells with exogenous Wnt3a (Figure 4.28), suggesting that Myc-derived 
cells require the PRC2 complex to activate the Wnt signalling through 
repression of its antagonists, as occur in Myc-maintained cells.  
Hence, to further analyse the silencing of Wnt antagonists, we performed 
ChIP experiments to quantify the binding of endogenous c- and N-Myc on 
the promoter of Dkk1 and Sfrp1. The same levels of c-Myc and higher N-
Myc levels were detected in Myc-derived ES cells compared to LIF-
maintained ES cells. (Figure 4.29). Furthermore, no significant changes in 
the amount of PRC2 complex or H3K27me3 levels on the promoter of Dkk1 
and Sfrp1 could be detected among LIF and Myc-derived ES cells (Figure 
4.29). Taken together, these results suggest that Wnt antagonists are kept 
repressed by endogenous Myc proteins through PRC2 recruitment. This 
leads to reinforcement of the autocrine Wnt signalling, which sustains the 
expression of endogenous c- and N-Myc genes. This positive feedback 
loop could sustain self-renewal capacity of ES cells even in absence of 
environmental cues. 
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Figure 4.28 PRC2 biochemical activity is required to sustain self-renewal in Myc-
derived ES cells.  
AP staining of MycER ES cells grown for three days in the indicated conditions and relative 
quantification of positive colonies are represented as percentage of the total colonies 
formed. Representative images of stained ES cells are shown. Scale bar = 200 µm. Error 
bars represent standard deviation from 3 independent experiments. *p<0.05; **p<0.01.  
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Figure 4.29 Myc-derived ES cells have PRC2 on Wnt antagonists promoters.  
Chromatin extracts were obtained from either the MycER ES cells maintained in LIF- or 
Myc-dependency or the Myc-derived ES cells (-Myc). The level of H3K27me3 and the 
binding of Myc, N-Myc and Suz12 at the TSS of the indicated genes were measured by 
ChIP assay, (n=4). 
 
 
To exclude the possibility that self-renewal and pluripotency ability of Myc-
derived ES cells was due to genetic modification, we performed a 
karyotype analysis, which showed that Myc-derived cells remain euploid 
after prolonged culture, since they showed a proper set of chromosomes 
(n=40) (Figure 4.30A). 
Moreover, upon reverse adaptation to grow in LIF containing medium, the 
Myc-derived ES cells (called LIF-reprogrammed, rLIF) returned sensitive to 
the LIF/Stat3 pathway, as observed by the strongly reduction of AP+ 
colonies when treated with two different inhibitors of the JAK pathway, 
AG490 and Jaki1 (Figure 4.30B). On the other hand, they returned to be 
unresponsive both to the functional activity of PRC2, if treated with EPZ 
and GSK126 inhibitors, and to Wnt pathway activity, if treated with XAV939 
and Dkk1/Sfrp1inhibitors (Figure 4.30B). 
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Figure 4.30 Myc-derived ES cells are euploid and are able to revert into a LIF-
dependent state.  
(A) karyotype analysis of Myc-derived ES cells at passage 30. (B) AP staining of MycER ES 
cells grown for three days in the indicated conditions and relative quantification of positive 
colonies are represented as percentage of the total colonies formed. Error bars represent 
standard deviation from 3 independent experiments. *p<0.05; **p<0.01; ***p<0.001. 
 
 
Finally, we measured the transcriptional levels of Wnt antagonists, Dkk1 
and Sfrp1, in LIF-reprogrammed ES cells in order to confirm the reversion 
of the self-reinforcing positive feed-back loop. qPCR analysis showed that 
gene expression levels of Dkk1 and Sfrp1 were up-regulated at similar 
levels to LIF-maintained ES cells (Figure 4.31). Taken together, these 
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results showed that in order to establish a positive feedback loop, c-Myc 
requires the biological activity of PRC2, and that this self-reinforcing circuit 
can be reverted upon  treatment with LIF. 
 
 
 
	  
Figure 4.31 Dkk1 and Sfrp1 expression levels.  
The relative transcriptional level of Dkk1 and Sfrp1 was confirmed by qRT-PCR analysis on 
RNAs extracted from ES cells grown in the indicated conditions for three days. Error bars 
represent standard deviation from 3 independent experiments. ***p<0.001. 	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4.3 c-MYC acts as tumor reprogramming factor in human 
mammary epithelial cells by inducing stem cell-like fate 
Recent findings shown the existence on neoplastic tissues of a 
subpopulation of tumor cells, called Cancer Stem Cells (CSCs), that carries 
similar properties to those that characterize normal stem cells. Despite their 
attractiveness, the molecular mechanisms underlying their formation are 
poorly understood. Several works have shown evidences implicating 
progenitor cells as targets of neoplastic transformation, induced by the 
reacquisition of self-renewal capacity, through accumulation of a number of 
genetic and epigenetic modifications [Cozzio et al., 2003; Krivtsov et al., 
2006]. Furthermore, recent works demonstrated that TFs network play an 
important role in establishing cellular states, including the SC state 
[Polytarchou et al., 2012; Rheinbay et al., 2013]. 
Given the previous considerations, we hypothesized that c-MYC over-
expression in committed mammary epithelial cells could induce their 
reprogramming to a stem cell-like state. 
To address this issue, as model we used a human hTERT-immortalized 
mammary epithelial cell (IMEC) line in which we induced constitutive c-
MYC over-expression (IMEC MYC) (Figure 4.32A). We observed that 
constitutive c-MYC over-expression in IMEC induced loss of the typical 
epithelial phenotype. In fact, after the first divisions, cells started to detach 
and grew as semi-adherent spheroids (mammospheres) (Figure 4.32B). In 
particular, while IMEC WT cells divide parallel to the culture plane, about 
50% of cells over-expressing c-MYC divide by tilting their mitotic spindle 
until to 25°C (Figure 4.32C).  
Further analysis indicated that this loss of cell polarity is combined to a 
disorganization of adherent junctions, in term of β-Catenin distribution and 
to a general reduction of β-Catenin and Cadherin protein levels (Figure 
4.33). 
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Figure 4.32	  c-­‐MYC	  over-­‐expression	  causes	  loss	  of	  cell	  polarity	  in	  IMEC.	  	  
(A) Western Blot analysis of proteins extracted from both IMEC WT and c-MYC. 
Immunostaining (IB) analysis was performed using the indicated antibodies; Actin was used 
as loading control. (B) Morphology of IMEC WT and c-MYC cells. Scale bar = 200 µm. (C) 
Immunofluorescence images and angle analysis of mitotic spindle. γ-Tubulin (poles) and 
DAPI (chromosomes) are shown. Scale bar = 10 µm. 
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Figure 4.33 Loss of adherent junctions in IMEC MYC.  
(A) Immunofluorescence images of the IMEC WT and MYC stained with β-Catenin and 
Phalloidin to highlight the cytoplasm. Scale bar = 100 µm. (B) Immunostaining (IB) analysis 
was performed using the indicated antibodies; Actin was used as loading control. (C) 
Histone quantification from Immunostaining analysis. 	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5. DISCUSSION 
5.1 c-Myc sustains self-renewal and pluripotency of ES 
cells 
Pluripotent stem cells are poised to differentiate into essentially all cell 
types in response to different environmental stimuli. In this context, the 
chromatin acts as molecular sensor of cellular signaling pathways activated 
in response to physiological and environmental stimuli and allows changes 
in gene expression pattern that can be stably maintained during cell 
division, therefore establishing a defined cell identity.  
A well-known signaling pathway, with a crucial role in Embryonic Stem (ES) 
cells maintenance, is initiated by the cytokine Leukemia Inhibitory Factor 
(LIF). LIF acts via the glycoprotein-130 receptor, to promote a JAK-STAT3 
signaling cascade [Raz et al., 1999], which integrates into the core of the 
Transcriptional Regulatory Network (TRN) by co-occupying enhancers 
bound by Oct4, Sox2 and Nanog [Chen et al., 2008]. More recently, it has 
been shown that dual inhibition of Erk and Gsk3b signaling pathways is 
able to prevent ES cells differentiation [Ying et al., 2008]. The ES cells 
dependency on LIF-STAT3 pathway could be circumvented by enforced 
expression of pluripotency factors [Chambers et al., 2003; Niwa et al., 
2009; Cartwright et al., 2005]. Among these, the Myc family members, c-
Myc and N-Myc have been described to modulate self-renewal and 
pluripotency of ES cells. Despite numerous studies have demonstrated the 
crucial role of c-Myc in sustaining pluripotency [Cartwright et al., 2005; Neri 
et al., 2012; Smith et al., 2010], its mechanisms of action are still not 
completely described. Until now, it has been proposed that c-Myc can 
sustain self-renewal and cell proliferation of ES cells by regulating specific 
set of genes from those regulated by the TRN [Chen et al., 2008; Kim et al., 
2010]. Moreover, it has been proposed that c-Myc acts as universal 
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amplifier by binding to the promoter regions of its target genes that cause a 
redistribution of RNA polymerase [Lin et al., 2012; Nie et al., 2012]. 
However, c-Myc not only acts as a transcriptional activator, but about 35% 
of its target genes are repressed. In fact, c-Myc can suppress primitive 
endoderm differentiation of pluripotent stem cells, by inhibiting the master 
regulator Gata6 [Smith et al., 2010] and, through miR-17-92 cluster, can 
suppress the expression of chromatin regulatory genes, to promote cell 
proliferation [Li et al., 2014]. Although it is very tempting to conclude that c-
Myc has a crucial role in sustaining ES cells self-renewal, those works still 
did not prove the molecular mechanisms that underlie the Myc-dependent 
transcriptional repression. This study describes a new model in which Myc-
dependent self-renewal maintenance of ES cells is ensured by the Myc-
dependent repression of genes encoding for Wnt antagonists, in 
cooperation with the PRC2 complex.  
In our work, we used mouse ES cells which express a steroid-activable 
MycER construct [Cartwright et al., 2005]. We propose that controlling the 
amount of c-Myc, through 4-OHT induction, is crucial for the maintenance   
of ES cells self-renewal and pluripotency. Our data are in agreement with 
previous studies, showing that elevated activity of c-Myc can replace the 
LIF/Stat3 signaling in ES cells [Cartwright et al., 2005]. 	  
Gene expression profile analyses of Myc-maintained and LIF-dependent 
ES cells, together with Epiblast Stem cells (EpiSCs), used as control for a 
primed state of stemness, revealed that Myc-maintained ES cells cluster 
together with LIF-ES cells and are distant from EpiSCs. However, despite 
the observed similarities, a specific gene expression pattern distinguished 
Myc- from LIF-maintained ES cells. Ingenuity Patway Analysis (IPA) 
showed that JAK/Stat3 and Mapk pathway are over-represented in LIF, 
while the Wnt/β-Catenin signaling is enriched in Myc-maintained ES cells. 
One of the aims of this work was to determine whether c-Myc required the 
activation of Wnt pathway to support the pluripotency of ES cells. In fact, 
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several studies have demonstrated that the Wnt pathway can act as a 
niche factor to support the self-renewal of ES cells [Reya et al., 2003].  
Our data indicated a Myc-mediated reinforcement of the Wnt autocrine 
loop, including activation of the Fzd/Lrp receptor complex resulting in the 
phosphorylation of Lrp6. Moreover we showed that MycER activity 
significantly affects the protein levels of active β-Catenin. This could be the 
result of inhibition of the β-Catenin destruction complex, due to reduction of 
the rate-limiting component Axin1 and of 
Gsk3β, via Akt-mediated phosphorylation [Li et al., 2012; Kim et al., 2013].  
These results are consistent with a previous study in which it was shown 
how, after inhibition of the function of β-Catenin negative regulators, Wnt 
signaling can promote the undifferentiated phenotype of mouse ES cells 
[Kielman et al., 2002] through active β-Catenin, that moves to the nucleus 
and binds the downstream effectors Tcf1 and Tcf3 [Nusse, 2005]. 
Moreover, we demonstrated that c-Myc represses transcription of the Wnt 
antagonists Dkk1 and Sfrp1, therefore reinforcing the Wnt pathway activity. 
Several studies showed that Dkk1 and Sfrp1 promoters contain bivalent 
domains and are Polycomb targets [Trenkmann et al., 2011; Kaur and 
Cole, 2013]. Furthermore, it was observed that a subset of Polycomb target 
genes, with bivalent histone methylation patterns, are bound and regulated 
in response to altered c-Myc levels [Lin et al., 2009]. Given those findings, 
we propose that c-Myc can recruit Polycomb complex on the promoters of 
these genes to keep them repressed. In this work we demonstrated, by 
using different approaches, that c-Myc associates with the PRC2 complex 
through direct interaction with the core proteins Eed and Aebp2. 
Interestingly, among the PcG proteins, Aebp2 is the only transcription 
factor, which has been shown to have some degree of specificity in DNA 
binding [Kim et al., 2009]. The close association of c-Myc with Aebp2 within 
the PRC2 complex invokes the possibility of a synergism in the DNA-
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binding recognition of the PRC2 complex, thus favoring the selection for 
specific loci. We show that c-Myc interacts with the Polycomb members 
Eed and Aebp2 through the MBII domain. This is a notable finding, since it 
has been shown that this domain is required for Myc-dependent cell 
transformation, because of its crucial role in the recruitment of multiprotein 
enzymatic complexes [Adhikary and Eilers, 2005]. Considering that Myc-
dependent recruitment of the proper cofactor to a specific target gene is 
crucial for the transcriptional outcome, it is likely that a combination of 
events, including intracellular signaling that induce post-translational 
modifications, may play an important role in the selection of alternative 
complexes. The functional analysis reported in this work, based on shRNA-
knockdowns, demonstrate that the integrity and biochemical activity of the 
PRC2 is required for Myc-mediated repression. Importantly, we showed 
that PRC2-dependent impairment of Myc-maintained ES cell self-renewal 
was restored upon reactivation of Wnt pathway. Our study is the first to 
report that c-Myc causes transcriptional repression by directly recruiting 
histone modifier on its target genes.  
Although we do not exclude the possibility that c-Myc participates in 
recruiting PRC2 to other Polycomb target genes, involved in cell lineage 
commitment, our findings suggest an alternative role of PRC2 in ES cells. 
In fact, PRC2 has been described until now as a player in lineage priming 
with mild effects on self-renewal capacity [Leeb et al., 2010; Di Croce and 
Helin, 2013]. Here we show that PRC2 actually participate in the fine-tuning 
of Wnt signaling, thus sustaining self-renew of Myc-maintained ES cells. 
The apparent discrepancy between our findings and previous reports could 
be explained by considering that the role of PRC2 in self-renewal have 
been evaluated in ES cells grown in LIF-dependency [Boyer et al., 2006; 
Leeb et al., 2010] or in 2i medium [Riising et al., 2014], where other 
signaling cascades counterbalance the improper inhibition of the autocrine 
Wnt/β-Catenin pathway, as consequence of PRC2 inactivation.  
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We have shown a critical interplay between c-Myc activation and the 
autocrine Wnt/β-Catenin signaling, which drives the onset of a positive 
feedback loop through the transcriptional activation of the endogenous c- 
and N-Myc genes. This network motif stabilizes the TRN by counteracting 
the transcriptional repression activity of Tcf3, possibly through its 
association with β-Catenin, thus recapitulating the ground state of ES cells 
[Ying et al., 2008] (Figure 5.1). 
 
 
 
	  
Figure 5.1 Network visualization of the Myc-mediated machinery to sustain ES cells 
self-renewal.  
Three main molecular modules are shown, from right to left: the LIF signal transduction 
module, the core Transcriptional Regulatory Network (TRN), the Wnt/β-Catenin pathways 
and the Polycomb module. Network edges were manually curated according to literature 
knowledge, lab findings and completed querying interaction repositories: they indicate 
activation (arrowheads), inhibitions (T-shaped heads) and physical interactions (circle-
shaped head).  
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5.2 c-Myc establishes an epigenetic memory in ES cells 
generating a self-reinforcing positive feedback motif 
Many signaling pathways activated by environmental stimuli can establish 
Transcription Factors (TFs) networks, called “network motifs” [Shen-Orr et 
al., 2002; Milo et al., 2002]. Each motif has distinct properties, whose 
dynamic functions are achieved efficiently [Alon, 2007]. Although the 
specific components of corresponding networks motifs may vary greatly 
from one system to another, networks motifs represent the basic building 
block for the formation of cellular memory [Han et al., 2007]. Although it has 
been demonstrated that TFs networks are involved in establishing of 
cellular memory in prokaryotic cells, the molecular mechanisms through 
which they are able to act in eukaryotic cells have not been elucidated. In 
this work we report the central role of c-Myc in establishing an epigenetic 
memory in ES cells. Our data show that activation of MycER, by an 
external stimulus, establishes a positive feedback loop, by repressing the 
Wnt antagonists via PRC2 recruitment, thus sustaining Wnt signaling, 
which triggers the transcriptional activation of the endogenous c- and N-
Myc genes (Figure 5.2A).   
Several lines of evidence suggest that PRC-dependent silencing of Wnt 
antagonists is the main mediator of Myc-driven epigenetic memory in ES 
cells. First, the inhibition of Ezh2 methyltransferase activity shows that the 
biochemical function of the PRC2 is necessary to sustain ES cell self-
renewal. Furthermore, activation of Wnt pathway, by exogenous Wnt3a, is 
able to compensate for the PRC2 inhibition. Second, the expression of 
endogenous c- and N-Myc is dependent from Wnt signaling activation. 
Third, even in the absence of environmental stimuli, c-Myc is able to recruit 
PRC2 on the promoters of Wnt antagonists, Dkk1 and Sfrp1. 
Additional evidence for a role of c-Myc in establishing an epigenetic 
memory was obtained by reverse adaptation to the original culture 
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conditions. We find that, in agreement with general perspective of dynamic 
and reversible nature of histone post-translational modifications [Bernstein 
et al., 2007], the gene repression of Wnt antagonists in our system is highly 
specific and plastic, reverting back to the original steady state when given 
the appropriate environmental cues. Furthermore, upon reverse adaptation 
to growth in LIF containing medium, Myc-derived ES cells return sensitive 
to the LIF/Stat3 pathway, while returning to be unresponsive to the 
functional activity of PRC2 and Wnt pathway. 
If c-Myc establishes an epigenetic memory and ES cells are able to self-
renew in absence of further inputs, from either the ectopically expressed 
MycER protein or from exogenous LIF signaling, we would expect that 
Myc-derived ES cell were able to differentiate into all three germ layers. 
Indeed, we found that expression of lineage-specific genes increased when 
Myc-derived ES cells were induced to EBs differentiation. Therefore, Myc-
derived ES cells were able to generate EpiSC in culture, a pivotal event in 
cellular differentiation [ten Berge et al., 2011]. Our results not only 
demonstrate that Myc-derived ES cells differentiate in vitro, but also that 
they are able to generate teratomas once injected in Nude mice. 
As revealed in this study, for a cellular memory to be established, cells 
must be subjected to a prolonged stimulus for the required period (Figure 
5.2B). Our data are in agreement with previous studies showing that if the 
feedback is weak, in response to a short stimulus the system returns to the 
basal level. As the feedback strength increases, the response to a stimulus 
can become irreversible and upon decreasing the stimulus to zero, the 
system still remains active [Xiong and Ferrell, 2003]. 
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Figure 5.2 Schematic representation of experimental data.  
(A) Signaling module composed of a positive feedback motif. (B) Response of a signaling 
module after different timing of stimulation.  
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5.3 c-MYC acts as tumor reprogramming factor in human 
mammary epithelial cells by inducing stem cell-like fate 
Breast cancer is the most common cancer in woman with a mortality rate of 
17% of all deaths due to cancer. About 12% of woman will develop invasive 
breast cancer during their lifetime [National Cancer Institute, NIH]. Cancer 
is both a genetic and epigenetic disease and epigenetic allows the genome 
to intrinsically integrate with environmental signals [Jaenisch and Bird, 
2003]. These three determinants represent the major driving forces of 
tumorigenesis and they cause the functional heterogeneity observed in 
most of the cancer types. Evidence is accumulating that both normal and 
fully neoplastic cell populations harbor subpopulations of stem cells, which 
can both self-renew and spawn more differentiated progeny, that in the 
case of Cancer Stem Cells  (CSCs) form the great bulk of many tumors 
[Chaffer and Weinberg, 2015]. However, the regulators that control the 
adult stem cells state are poorly understood, particularly in epithelial 
tissues. Given the previous considerations, along with the fact that SCs 
have a longer lifespan than more differentiated cells, the current view 
depicts normal SCs as the initial targets of oncogenic transformation. 
Accordingly, the population of normal SCs would accumulate a number of 
genetic alterations, until the CSCs population arises in a highly malignant 
tumor. However, this model is affected by at least two inconsistences: 
normal SCs population is too small and too rarely dividing to have the 
chance to accumulate more stochastic changes that confer advantage 
phenotype [Chaffer and Weinberg, 2015]. An alternative process seems to 
suggest a more likely model of how multistep tumor progression really 
proceeds. In this model transit amplifying progenitor cells, that are 
mitotically more active and more numerous than SCs, may serve as targets 
of somatic and epigenetic aberrations that can cause their alteration and 
de-differentiation to SCs. So, hierarchically organized cell populations 
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result more plastic than previously imagined [Chaffer and Weinberg, 2015]. 
In this view, cell transformation can be described as a cell reprogramming 
process towards a stem cell-like state in which a committed cell has to 
overcome a number of epigenetic barriers in order to alter its identity. 
Moreover, developmental studies have demonstrated that TFs play an 
important role in establishing cellular states, including the SC state 
[Polytarchou et al., 2012; Rheinbay et al., 2013].  
Here we report the central role of c-MYC in inducing reprogramming to a 
stem cell-like state in committed mammary epithelial cells. In particular, 
over-expression of c-MYC is sufficient to induce loss of both the typical 
epithelial cell phenotype and cell polarity, as the cells start to grow as non-
adherent spheroids. In agreement with the results obtained with ES cells, 
preliminary data suggest that it could happen through hyper activation of 
the autocrine Wnt pathway, caused by MYC-driven epigenetic silencing of 
two major inhibitors of the wnt pathway, Dkk1 and Sfrp1 (Figure 5.3). 
 
 
Figure 5.3 Schematic representation of experimental data.  
[Modified from Visvader, 2011]  	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6. CONCLUSION 
This work addressed the suspected role of the c-Myc protein in the 
regulation of self-renewal and pluripotency in mouse ES cells and it 
describes a molecular mechanism that can explain this ability. Our findings 
expose new evidence for Myc-induced transcriptional repression and for 
the first time it is shown that this occurs through the direct interaction 
between c-Myc and histone modifiers. 
Although our study requires additional experiments in order to finalize some 
important results, it seems likely that cross-talk between environmental 
stimuli and TFs network motifs are the basis for the formation of cellular 
memories. 
It is hoped that this work will stimulate further interest to study how 
differently TFs network motifs can interact and change or maintain a 
specific cell identity in response to different environmental stimuli. For 
instance, translating these studies to human ES cells would represent an 
enormous promise for regenerative medicine. However, how the epigenetic 
stability of hES cells is maintained in xeno-free culture conditions was 
poorly investigated so far.  
Furthermore, the deregulation of TFs, concomitantly with epigenetic 
alterations, plays an important role in many types of cancer. However how 
the TFs interconnect between environmental stimuli and determine the 
reprogramming to SC-like state in tumor are poorly understood. A 
characterization of these networks could be of significance importance in 
order to identify new therapeutic targets, since treatment failure is often the 
result of CSCs escape from traditional therapies. 
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APPENDIX 
 
A. List of Primers 
Primer Sequence Application 
Sfrp1 Fwd CCGGCCCATCTACCCGTGTC qPCR 
Sfrp1 Rev ACCGTTGTGCCTTGGGGCTT qPCR 
Dkkl1 Fwd GAACACCTCCGGGTTCCT qPCR 
Dkkl1 Rev TCCAGGTCTCGTAGCAGGTC qPCR 
Dkk1 Fwd CCGGGAACTACTGCAAAAAT qPCR 
Dkk1 Rev CCAAGGTTTTCAATGATGCTT qPCR 
Sfrp5 Fwd GATCTGTGCCCAGTGTGAGA qPCR 
Sfrp5 Rev TTAATGCGCATCTTGACCAC qPCR 
Tle5 Fwd CGCGACTGACATGATGTTTC qPCR 
Tle5 Rev GAGTCGGAGGTGGTGAACTT qPCR 
Tle2 Fwd TGGCACCAGCTATCCACAC qPCR 
Tle2 Rev AGGCGTTTCACAATCTCAGC qPCR 
Lef1 Fwd TCCTGAAATCCCCACCTTCT qPCR 
Lef1 Rev TGGGATAAACAGGCTGACCT qPCR 
Rspo1 Fwd CGACATGAACAAATGCATCA qPCR 
Rspo1 Rev CTCCTGACACTTGGTGCAGA qPCR 
Lrp5 Fwd CATGGACATCCAAGTGCTGA qPCR 
Lrp5 Rev TTGTCCTCCTCGCATGGT qPCR 
Fzd3 Fwd GCAGCCTCCACAGGTCAC qPCR 
Fzd3 Rev ACATGCTGCCGTGAGGTAG qPCR 
Fzd7 Fwd GCCATTTGACTTGAAACTTGG qPCR 
Fzd7 Rev TCCGCCTTCTCTCCTTGAG qPCR 
Fzd2 Fwd ATCTGGTCCGGCAAGACA qPCR 
Fzd2 Rev GCTGTTGGTGAGACGAGTGTA
G 
qPCR 
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Dkk1 promoter Fwd AGAGGGCTTGCTTTTGATCC ChIP 
Dkk1 promoter Rev TTCCTCCTGTCCTGTCCTGT ChIP 
Sfrp1 promoter Fwd CACCCAGGTCTTCCTCTGTT ChIP 
Sfrp1 promoter Rev AGCGACACGGGTAGATGG ChIP 
Pax6 Fwd CACCAGACTCACCTGACACC qPCR 
Pax6 Rev ACCGCCCTTGGTTAAAGTC qPCR 
Gata6 Fwd GGTCTCTACAGCAAGATGAAT
GG 
qPCR 
Gata6 Rev TGGCACAGGACAGTCCAAG qPCR 
Pecam1 Fwd CAAAGTGGAATCAAACCGTAT
CT 
qPCR 
Pecam1 Rev CTACAGGTGTGCCCGAG qPCR 
Oct4 Fwd TGGGGGCAGAGAAGATGGTTG qPCR 
Oct4 Rev AAGGCAGCGACTTGGAAGCC  qPCR 
Sox2 Fwd TTTTCGTTTTTAGGGTAAGGTA
CTGGGAAG 
 
qPCR 
Sox2 Rev CCACGTGAATAATCCTATATGC
ATCACAAT 
 
qPCR 
Klf2 Fwd TCGAGGCTAGATGCCTTGTGA qPCR 
Klf2 Rev AAACGAAGCAGGCGGCAGA qPCR 
Fgf5 Fwd AAAACCTGGTGCACCCTAGA qPCR 
Fgf5 Rev CATCACATTCCCGAATTAAGC qPCR 
Wnt3 Fwd CAGTGCCTGAGTGGGAGATT qPCR 
Wnt3 Rev AGGGACTTCAGACCCGAGAT qPCR 
N-Myc Fwd CCTCCGGAGAGGATACCTTG qPCR 
N-Myc Rev TCTCTACGGTGACCACATCG qPCR 
c-Myc Fwd CCTAGTGCTGCATGAGGAGA qPCR 
c-Myc Rev TCCACAGACACCACATCAATTT qPCR 
Nanog Fwd GCCTCCAGCAGATGCAAG qPCR 
Nanog Rev GGTTTTGAAACCAGGTCTTAAC
C 
qPCR 
Fwd_XhoI Eed  CATACTCGAGATGTCCGAGAG Cloning 
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GGAAGTGTC 
 
Rev_BamHI Eed TATTGGATCCTTATCGAAGTCG
ATCCCAGCG 
 
Cloning 
Fwd_XhoI Ezh2 CATACTCGAGATGGGCCAGAC
TGGGAAGA 
 
Cloning 
Rev_BamHI Ezh2 TATTGGATCCTCAAGGGATTTC
CATTTCTCTTTC 
 
Cloning 
Fwd_XhoI Aebp2 AGATCTCGAGATGGCCGCCGC
TATCACC 
 
Cloning 
Rev_EcoRI Aebp2 TGCAGAATTCCCTCTTCAACCT
CTTCTG 
 
Cloning 
Fwd_XhoI c-Myc AGATCTCGAGCTGGATTTTTTT
CGGGTA 
 
Cloning 
Rev_BamHI c-Myc GGTGGATCCTTACGCACAAGA
GTTCCGT 
Cloning 
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B. List of Antibodies 
Antibody Code  Seller Application 
p44/42 (Erk1/2) 9102 Cell Signaling WB 
ph-p44/4 (Erk1/2) 
(Thr202/Tyr204) 
(D13.14.4E) 
4370 Cell Signaling WB 
LRP6 (C47E12)  3395 Cell Signaling WB 
ph-LRP6 (Ser1490) 2568 Cell Signaling WB 
β−Catenin 8480 Cell Signaling WB 
Active β-Catenin 
(D13A1) 
8814 Cell Signaling WB 
Axin1 (C76H11) 2087 Cell Signaling WB 
Tcf1 (C63D9) 2203 Cell Signaling WB, PLA 
Tcf3 SAB2102977 Sigma WB, PLA 
Tle3 (M-201) sc-9124 Santa Cruz WB 
Tle4 (E-10) sc-365406 Santa Cruz WB 
Gsk-3β (27C10) 9315 Cell Signaling WB 
Phospho-Gsk-3β (Ser9) 
(5B3) 
9323 Cell Signaling WB 
Akt (pan) (40D4) 2920 Cell Signaling WB 
ph-Akt (Ser473) (D9E) 4060 Cell Signaling WB 
Ezh2 (AC22) 3147 Cell Signaling WB 
Suz12 (D39F6) 3737 Cell Signaling WB, ChIP 
Eed (AA19) 05-1320 Millipore WB 
Lamin B (B-10) sc-374015 Santa Cruz WB 
β−Catenin 610153 BD PLA 
c-Myc (D84C12) 5605 Cell Signaling WB, ChIP 
β-Tubulin (H-235) sc-9104 Santa Cruz WB 
Histone H3-trimethyl-
K27 
07-449 Millipore ChIP 
Histone H3-trimethyl-K4 07-473 Millipore ChIP 
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Histone H3 9715 Cell Signaling WB 
Gapdh (6C5) sc-32233 Santa Cruz WB 
Oct-3/4 (C-10) sc-5279 Santa Cruz WB 
Sox-2 (Y-17) sc-17320 Santa Cruz WB 
Nanog A300-397A Bethyl WB 
Klf4 (H-180) sc-20691 Santa Cruz WB 
β−actina A5441 Sigma WB 
N-Myc (NCM II 100) OP13 Calbiochem WB, ChIP 
γ-Tubulin T6557 Sigma IF 
E-Cadherin 610182 BD Pharingen IF, WB 
Pan-Cadherin Ab6528 abcam WB 
Phalloidin P1951 Sigma IF 	  	  	  	  
